#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Dynamic functional connectivity impairments in early schizophrenia and clinical high-risk for psychosis Individuals at clinical high-risk (CHR) for psychosis are characterized by attenuated psychotic symptoms.
1-1	0-7	Dynamic	_
1-2	8-18	functional	_
1-3	19-31	connectivity	_
1-4	32-43	impairments	_
1-5	44-46	in	_
1-6	47-52	early	_
1-7	53-66	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-8	67-70	and	_
1-9	71-79	clinical	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalDocument
1-10	80-89	high-risk	_
1-11	90-93	for	http://maven.renci.org/NeuroBridge/neurobridge#CenterForEpidemiologicStudiesDepressionScale
1-12	94-103	psychosis	_
1-13	104-115	Individuals	_
1-14	116-118	at	_
1-15	119-127	clinical	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus
1-16	128-137	high-risk	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus
1-17	138-139	(	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus
1-18	140-143	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus
1-19	144-145	)	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus
1-20	146-149	for	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus
1-21	150-159	psychosis	_
1-22	160-163	are	_
1-23	164-177	characterized	_
1-24	178-180	by	_
1-25	181-191	attenuated	_
1-26	192-201	psychotic	_
1-27	202-210	symptoms	_
1-28	211-212	.	_

Text=Only a minority of CHR individuals convert to full-blown psychosis.
2-1	213-217	Only	_
2-2	218-219	a	_
2-3	220-228	minority	_
2-4	229-231	of	_
2-5	232-235	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
2-6	236-247	individuals	_
2-7	248-255	convert	_
2-8	256-258	to	_
2-9	259-269	full-blown	_
2-10	270-279	psychosis	_
2-11	280-281	.	_

Text=Therefore, there is a strong interest in identifying neurobiological abnormalities underlying the psychosis risk syndrome.
3-1	282-291	Therefore	_
3-2	292-293	,	_
3-3	294-299	there	_
3-4	300-302	is	_
3-5	303-304	a	_
3-6	305-311	strong	_
3-7	312-320	interest	_
3-8	321-323	in	_
3-9	324-335	identifying	_
3-10	336-351	neurobiological	_
3-11	352-365	abnormalities	_
3-12	366-376	underlying	_
3-13	377-380	the	_
3-14	381-390	psychosis	_
3-15	391-395	risk	_
3-16	396-404	syndrome	_
3-17	405-406	.	_

Text=Dynamic functional connectivity (DFC) captures time-varying connectivity over short time scales, and has the potential to reveal complex brain functional organization.
4-1	407-414	Dynamic	_
4-2	415-425	functional	_
4-3	426-438	connectivity	_
4-4	439-440	(	_
4-5	441-444	DFC	_
4-6	445-446	)	_
4-7	447-455	captures	_
4-8	456-468	time-varying	_
4-9	469-481	connectivity	_
4-10	482-486	over	_
4-11	487-492	short	_
4-12	493-497	time	_
4-13	498-504	scales	_
4-14	505-506	,	_
4-15	507-510	and	_
4-16	511-514	has	_
4-17	515-518	the	_
4-18	519-528	potential	_
4-19	529-531	to	_
4-20	532-538	reveal	_
4-21	539-546	complex	_
4-22	547-552	brain	_
4-23	553-563	functional	_
4-24	564-576	organization	_
4-25	577-578	.	_

Text=Based on resting-state functional magnetic resonance imaging (fMRI) data from 70 healthy controls (HCs), 53 CHR individuals, and 58 early illness schizophrenia (ESZ) patients, we applied a novel group information guided ICA (GIG-ICA) to estimate inherent connectivity states from DFC, and then investigated group differences.
5-1	579-584	Based	_
5-2	585-587	on	_
5-3	588-601	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-4	602-612	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-5	613-621	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-6	622-631	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-7	632-639	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-8	640-641	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-9	642-646	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-10	647-648	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-11	649-653	data	_
5-12	654-658	from	_
5-13	659-661	70	_
5-14	662-669	healthy	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
5-15	670-678	controls	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
5-16	679-680	(	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
5-17	681-684	HCs	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
5-18	685-686	)	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
5-19	687-688	,	_
5-20	689-691	53	_
5-21	692-695	CHR	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
5-22	696-707	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
5-23	708-709	,	_
5-24	710-713	and	_
5-25	714-716	58	_
5-26	717-722	early	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-27	723-730	illness	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-28	731-744	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-29	745-746	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-30	747-750	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-31	751-752	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-32	753-761	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-33	762-763	,	_
5-34	764-766	we	_
5-35	767-774	applied	_
5-36	775-776	a	_
5-37	777-782	novel	_
5-38	783-788	group	_
5-39	789-800	information	_
5-40	801-807	guided	_
5-41	808-811	ICA	_
5-42	812-813	(	_
5-43	814-821	GIG-ICA	_
5-44	822-823	)	_
5-45	824-826	to	_
5-46	827-835	estimate	_
5-47	836-844	inherent	_
5-48	845-857	connectivity	_
5-49	858-864	states	_
5-50	865-869	from	_
5-51	870-873	DFC	_
5-52	874-875	,	_
5-53	876-879	and	_
5-54	880-884	then	_
5-55	885-897	investigated	_
5-56	898-903	group	_
5-57	904-915	differences	_
5-58	916-917	.	_

Text=We found that ESZ patients showed more aberrant connectivities and greater alterations than CHR individuals.
6-1	918-920	We	_
6-2	921-926	found	_
6-3	927-931	that	_
6-4	932-935	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-5	936-944	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-6	945-951	showed	_
6-7	952-956	more	_
6-8	957-965	aberrant	_
6-9	966-980	connectivities	_
6-10	981-984	and	_
6-11	985-992	greater	_
6-12	993-1004	alterations	_
6-13	1005-1009	than	_
6-14	1010-1013	CHR	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
6-15	1014-1025	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
6-16	1026-1027	.	_

Text=Results also suggested that disease-related connectivity states occurred in CHR and ESZ groups.
7-1	1028-1035	Results	_
7-2	1036-1040	also	_
7-3	1041-1050	suggested	_
7-4	1051-1055	that	_
7-5	1056-1071	disease-related	_
7-6	1072-1084	connectivity	_
7-7	1085-1091	states	_
7-8	1092-1100	occurred	_
7-9	1101-1103	in	_
7-10	1104-1107	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
7-11	1108-1111	and	_
7-12	1112-1115	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
7-13	1116-1122	groups	_
7-14	1123-1124	.	_

Text=Regarding the dominant state with the highest contribution to dynamic connectivity, ESZ patients exhibited greater impairments than CHR individuals primarily in the cerebellum, frontal cortex, thalamus and temporal cortex, while CHR and ESZ populations shared common aberrances mainly in the supplementary motor area, parahippocampal gyrus and postcentral cortex.
8-1	1125-1134	Regarding	_
8-2	1135-1138	the	_
8-3	1139-1147	dominant	_
8-4	1148-1153	state	_
8-5	1154-1158	with	_
8-6	1159-1162	the	_
8-7	1163-1170	highest	_
8-8	1171-1183	contribution	_
8-9	1184-1186	to	_
8-10	1187-1194	dynamic	_
8-11	1195-1207	connectivity	_
8-12	1208-1209	,	_
8-13	1210-1213	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-14	1214-1222	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-15	1223-1232	exhibited	_
8-16	1233-1240	greater	_
8-17	1241-1252	impairments	_
8-18	1253-1257	than	_
8-19	1258-1261	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
8-20	1262-1273	individuals	_
8-21	1274-1283	primarily	_
8-22	1284-1286	in	_
8-23	1287-1290	the	_
8-24	1291-1301	cerebellum	_
8-25	1302-1303	,	_
8-26	1304-1311	frontal	_
8-27	1312-1318	cortex	_
8-28	1319-1320	,	_
8-29	1321-1329	thalamus	_
8-30	1330-1333	and	_
8-31	1334-1342	temporal	_
8-32	1343-1349	cortex	_
8-33	1350-1351	,	_
8-34	1352-1357	while	_
8-35	1358-1361	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
8-36	1362-1365	and	_
8-37	1366-1369	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
8-38	1370-1381	populations	_
8-39	1382-1388	shared	_
8-40	1389-1395	common	_
8-41	1396-1406	aberrances	_
8-42	1407-1413	mainly	_
8-43	1414-1416	in	_
8-44	1417-1420	the	_
8-45	1421-1434	supplementary	_
8-46	1435-1440	motor	_
8-47	1441-1445	area	_
8-48	1446-1447	,	_
8-49	1448-1463	parahippocampal	_
8-50	1464-1469	gyrus	_
8-51	1470-1473	and	_
8-52	1474-1485	postcentral	_
8-53	1486-1492	cortex	_
8-54	1493-1494	.	_

Text=CHR-specific changes were also found in the connections between the superior frontal gyrus and calcarine cortex in the dominant state.
9-1	1495-1507	CHR-specific	_
9-2	1508-1515	changes	_
9-3	1516-1520	were	_
9-4	1521-1525	also	_
9-5	1526-1531	found	_
9-6	1532-1534	in	_
9-7	1535-1538	the	_
9-8	1539-1550	connections	_
9-9	1551-1558	between	_
9-10	1559-1562	the	_
9-11	1563-1571	superior	_
9-12	1572-1579	frontal	_
9-13	1580-1585	gyrus	_
9-14	1586-1589	and	_
9-15	1590-1599	calcarine	_
9-16	1600-1606	cortex	_
9-17	1607-1609	in	_
9-18	1610-1613	the	_
9-19	1614-1622	dominant	_
9-20	1623-1628	state	_
9-21	1629-1630	.	_

Text=Our findings show that CHR individuals generally show an intermediate functional connectivity pattern between HCs and SZ patients but also have unique connectivity alterations.
10-1	1631-1634	Our	_
10-2	1635-1643	findings	_
10-3	1644-1648	show	_
10-4	1649-1653	that	_
10-5	1654-1657	CHR	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
10-6	1658-1669	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
10-7	1670-1679	generally	_
10-8	1680-1684	show	_
10-9	1685-1687	an	_
10-10	1688-1700	intermediate	_
10-11	1701-1711	functional	_
10-12	1712-1724	connectivity	_
10-13	1725-1732	pattern	_
10-14	1733-1740	between	_
10-15	1741-1744	HCs	http://maven.renci.org/NeuroBridge/neurobridge#Thing
10-16	1745-1748	and	_
10-17	1749-1751	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-18	1752-1760	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-19	1761-1764	but	_
10-20	1765-1769	also	_
10-21	1770-1774	have	_
10-22	1775-1781	unique	_
10-23	1782-1794	connectivity	_
10-24	1795-1806	alterations	_
10-25	1807-1808	.	_

Text=2.
11-1	1809-1810	2	_
11-2	1811-1812	.	_

Text=Materials and methods 2.1.
12-1	1813-1822	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-2	1823-1826	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-3	1827-1834	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-4	1835-1838	2.1	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-5	1839-1840	.	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod

Text=Materials Resting-state fMRI data from 70 HCs, 53 CHR individuals, and 58 ESZ patients were analyzed.
13-1	1841-1850	Materials	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
13-2	1851-1864	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
13-3	1865-1869	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
13-4	1870-1874	data	_
13-5	1875-1879	from	_
13-6	1880-1882	70	_
13-7	1883-1886	HCs	http://maven.renci.org/NeuroBridge/neurobridge#Thing
13-8	1887-1888	,	_
13-9	1889-1891	53	_
13-10	1892-1895	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
13-11	1896-1907	individuals	_
13-12	1908-1909	,	_
13-13	1910-1913	and	_
13-14	1914-1916	58	_
13-15	1917-1920	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-16	1921-1929	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-17	1930-1934	were	_
13-18	1935-1943	analyzed	_
13-19	1944-1945	.	_

Text=Table 1 shows the demographic and clinical information.
14-1	1946-1951	Table	_
14-2	1952-1953	1	_
14-3	1954-1959	shows	_
14-4	1960-1963	the	_
14-5	1964-1975	demographic	_
14-6	1976-1979	and	_
14-7	1980-1988	clinical	_
14-8	1989-2000	information	_
14-9	2001-2002	.	_

Text=There are no significant differences among the three groups on age or gender (p-value = 0.7 for gender examined by Chi Square test; p-value = 0.2 for age examined by analysis of variance).
15-1	2003-2008	There	_
15-2	2009-2012	are	_
15-3	2013-2015	no	_
15-4	2016-2027	significant	_
15-5	2028-2039	differences	_
15-6	2040-2045	among	_
15-7	2046-2049	the	_
15-8	2050-2055	three	_
15-9	2056-2062	groups	_
15-10	2063-2065	on	_
15-11	2066-2069	age	_
15-12	2070-2072	or	_
15-13	2073-2079	gender	_
15-14	2080-2081	(	_
15-15	2082-2089	p-value	_
15-16	2090-2091	=	_
15-17	2092-2095	0.7	_
15-18	2096-2099	for	_
15-19	2100-2106	gender	_
15-20	2107-2115	examined	_
15-21	2116-2118	by	_
15-22	2119-2122	Chi	_
15-23	2123-2129	Square	_
15-24	2130-2134	test	_
15-25	2135-2136	;	_
15-26	2137-2144	p-value	_
15-27	2145-2146	=	_
15-28	2147-2150	0.2	_
15-29	2151-2154	for	_
15-30	2155-2158	age	_
15-31	2159-2167	examined	_
15-32	2168-2170	by	_
15-33	2171-2179	analysis	_
15-34	2180-2182	of	_
15-35	2183-2191	variance	_
15-36	2192-2193	)	_
15-37	2194-2195	.	_

Text=CHR individuals were recruited from the University of California, San Francisco ’ s (UCSF) Prodromal Assessment, Research, and Treatment Clinic.
16-1	2196-2199	CHR	_
16-2	2200-2211	individuals	_
16-3	2212-2216	were	_
16-4	2217-2226	recruited	_
16-5	2227-2231	from	_
16-6	2232-2235	the	_
16-7	2236-2246	University	_
16-8	2247-2249	of	_
16-9	2250-2260	California	_
16-10	2261-2262	,	_
16-11	2263-2266	San	_
16-12	2267-2276	Francisco	_
16-13	2277-2278	’	_
16-14	2279-2280	s	_
16-15	2281-2282	(	_
16-16	2283-2287	UCSF	_
16-17	2288-2289	)	_
16-18	2290-2299	Prodromal	_
16-19	2300-2310	Assessment	_
16-20	2311-2312	,	_
16-21	2313-2321	Research	_
16-22	2322-2323	,	_
16-23	2324-2327	and	_
16-24	2328-2337	Treatment	_
16-25	2338-2344	Clinic	_
16-26	2345-2346	.	_

Text=Individuals recruited to the CHR group met the Criteria of Prodromal Syndromes (COPS) based on a Structured Interview for Prodromal Syndromes (SIPS).
17-1	2347-2358	Individuals	_
17-2	2359-2368	recruited	_
17-3	2369-2371	to	_
17-4	2372-2375	the	_
17-5	2376-2379	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
17-6	2380-2385	group	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
17-7	2386-2389	met	_
17-8	2390-2393	the	_
17-9	2394-2402	Criteria	_
17-10	2403-2405	of	_
17-11	2406-2415	Prodromal	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
17-12	2416-2425	Syndromes	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
17-13	2426-2427	(	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
17-14	2428-2432	COPS	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
17-15	2433-2434	)	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
17-16	2435-2440	based	_
17-17	2441-2443	on	_
17-18	2444-2445	a	_
17-19	2446-2456	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
17-20	2457-2466	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
17-21	2467-2470	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
17-22	2471-2480	Prodromal	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
17-23	2481-2490	Syndromes	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
17-24	2491-2492	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
17-25	2493-2497	SIPS	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
17-26	2498-2499	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredInterviewforProdromalSyndromesRatingScale
17-27	2500-2501	.	_

Text=The COPS comprises three non-mutually exclusive syndromes: Attenuated Positive Symptom Syndrome (APSS), Brief Intermittent Psychotic Syndrome (BIPS), and/or Genetic Risk and Deterioration Syndrome (GRD).
18-1	2502-2505	The	_
18-2	2506-2510	COPS	_
18-3	2511-2520	comprises	_
18-4	2521-2526	three	_
18-5	2527-2539	non-mutually	_
18-6	2540-2549	exclusive	_
18-7	2550-2559	syndromes	_
18-8	2560-2561	:	_
18-9	2562-2572	Attenuated	http://maven.renci.org/NeuroBridge/neurobridge#PositiveSymptomScale
18-10	2573-2581	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveSymptomScale
18-11	2582-2589	Symptom	http://maven.renci.org/NeuroBridge/neurobridge#PositiveSymptomScale
18-12	2590-2598	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveSymptomScale
18-13	2599-2600	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveSymptomScale
18-14	2601-2605	APSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveSymptomScale
18-15	2606-2607	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveSymptomScale
18-16	2608-2609	,	_
18-17	2610-2615	Brief	http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome
18-18	2616-2628	Intermittent	http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome
18-19	2629-2638	Psychotic	http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome
18-20	2639-2647	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome
18-21	2648-2649	(	http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome
18-22	2650-2654	BIPS	http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome
18-23	2655-2656	)	http://maven.renci.org/NeuroBridge/neurobridge#BriefIntermittentPsychoticSyndrome
18-24	2657-2658	,	_
18-25	2659-2665	and/or	_
18-26	2666-2673	Genetic	_
18-27	2674-2678	Risk	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-28	2679-2682	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-29	2683-2696	Deterioration	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-30	2697-2705	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-31	2706-2707	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-32	2708-2711	GRD	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-33	2712-2713	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-34	2714-2715	.	_

Text=The majority (92.5%) of CHR subjects met COPS criteria for APSS.
19-1	2716-2719	The	_
19-2	2720-2728	majority	_
19-3	2729-2730	(	_
19-4	2731-2735	92.5	_
19-5	2736-2737	%	_
19-6	2738-2739	)	_
19-7	2740-2742	of	_
19-8	2743-2746	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
19-9	2747-2755	subjects	_
19-10	2756-2759	met	_
19-11	2760-2764	COPS	http://maven.renci.org/NeuroBridge/neurobridge#Spectroscopy
19-12	2765-2773	criteria	_
19-13	2774-2777	for	_
19-14	2778-2782	APSS	http://maven.renci.org/NeuroBridge/neurobridge#Thing
19-15	2783-2784	.	_

Text=Supplementary Table S1 shows the number and percentage of CHR subjects with each syndrome.
20-1	2785-2798	Supplementary	_
20-2	2799-2804	Table	_
20-3	2805-2807	S1	_
20-4	2808-2813	shows	_
20-5	2814-2817	the	_
20-6	2818-2824	number	_
20-7	2825-2828	and	_
20-8	2829-2839	percentage	_
20-9	2840-2842	of	_
20-10	2843-2846	CHR	_
20-11	2847-2855	subjects	_
20-12	2856-2860	with	_
20-13	2861-2865	each	_
20-14	2866-2874	syndrome	_
20-15	2875-2876	.	_

Text=Clinical ratings of symptom severity in CHR individuals were obtained using the Scale of Prodromal Symptoms (SOPS), an embedded scale within the SIPS.
21-1	2877-2885	Clinical	_
21-2	2886-2893	ratings	_
21-3	2894-2896	of	_
21-4	2897-2904	symptom	_
21-5	2905-2913	severity	_
21-6	2914-2916	in	_
21-7	2917-2920	CHR	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
21-8	2921-2932	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
21-9	2933-2937	were	_
21-10	2938-2946	obtained	_
21-11	2947-2952	using	_
21-12	2953-2956	the	_
21-13	2957-2962	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
21-14	2963-2965	of	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
21-15	2966-2975	Prodromal	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
21-16	2976-2984	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
21-17	2985-2986	(	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
21-18	2987-2991	SOPS	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
21-19	2992-2993	)	http://maven.renci.org/NeuroBridge/neurobridge#ProdromalSymptom
21-20	2994-2995	,	_
21-21	2996-2998	an	_
21-22	2999-3007	embedded	_
21-23	3008-3013	scale	_
21-24	3014-3020	within	_
21-25	3021-3024	the	_
21-26	3025-3029	SIPS	_
21-27	3030-3031	.	_

Text=Most of the CHR subjects (41/53; 77%) were antipsychotic medication-naive at the time of scanning.
22-1	3032-3036	Most	_
22-2	3037-3039	of	_
22-3	3040-3043	the	_
22-4	3044-3047	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
22-5	3048-3056	subjects	_
22-6	3057-3058	(	_
22-7	3059-3064	41/53	_
22-8	3065-3066	;	_
22-9	3067-3069	77	_
22-10	3070-3071	%	_
22-11	3072-3073	)	_
22-12	3074-3078	were	_
22-13	3079-3092	antipsychotic	_
22-14	3093-3109	medication-naive	_
22-15	3110-3112	at	_
22-16	3113-3116	the	_
22-17	3117-3121	time	_
22-18	3122-3124	of	_
22-19	3125-3133	scanning	_
22-20	3134-3135	.	_

Text=ESZ patients within mean ± standard deviation = 2.08 ± 1.37 years of illness onset were recruited from an early psychosis clinic at UCSF and from community clinics.
23-1	3136-3139	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
23-2	3140-3148	patients	_
23-3	3149-3155	within	_
23-4	3156-3160	mean	_
23-5	3161-3162	±	_
23-6	3163-3171	standard	_
23-7	3172-3181	deviation	_
23-8	3182-3183	=	_
23-9	3184-3188	2.08	_
23-10	3189-3190	±	_
23-11	3191-3195	1.37	_
23-12	3196-3201	years	_
23-13	3202-3204	of	_
23-14	3205-3212	illness	_
23-15	3213-3218	onset	_
23-16	3219-3223	were	_
23-17	3224-3233	recruited	_
23-18	3234-3238	from	_
23-19	3239-3241	an	_
23-20	3242-3247	early	_
23-21	3248-3257	psychosis	_
23-22	3258-3264	clinic	_
23-23	3265-3267	at	_
23-24	3268-3272	UCSF	_
23-25	3273-3276	and	_
23-26	3277-3281	from	_
23-27	3282-3291	community	_
23-28	3292-3299	clinics	_
23-29	3300-3301	.	_

Text=Diagnosis of schizophrenia or schizoaffective disorder in ESZ participants was verified using the Structured Clinical Interview for DSM-IV (SCID), and symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS).
24-1	3302-3311	Diagnosis	_
24-2	3312-3314	of	_
24-3	3315-3328	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
24-4	3329-3331	or	_
24-5	3332-3347	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
24-6	3348-3356	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
24-7	3357-3359	in	_
24-8	3360-3363	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
24-9	3364-3376	participants	_
24-10	3377-3380	was	_
24-11	3381-3389	verified	_
24-12	3390-3395	using	_
24-13	3396-3399	the	_
24-14	3400-3410	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-15	3411-3419	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-16	3420-3429	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-17	3430-3433	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-18	3434-3440	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-19	3441-3442	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-20	3443-3447	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-21	3448-3449	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-22	3450-3451	,	_
24-23	3452-3455	and	_
24-24	3456-3463	symptom	_
24-25	3464-3472	severity	_
24-26	3473-3476	was	_
24-27	3477-3485	assessed	_
24-28	3486-3491	using	_
24-29	3492-3495	the	_
24-30	3496-3504	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
24-31	3505-3508	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
24-32	3509-3517	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
24-33	3518-3526	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
24-34	3527-3532	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
24-35	3533-3534	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
24-36	3535-3540	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
24-37	3541-3542	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
24-38	3543-3544	.	_

Text=Most ESZ patients (53/58; 91%) were taking antipsychotic medication at the time of testing.
25-1	3545-3549	Most	_
25-2	3550-3553	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
25-3	3554-3562	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
25-4	3563-3564	(	_
25-5	3565-3570	53/58	_
25-6	3571-3572	;	_
25-7	3573-3575	91	_
25-8	3576-3577	%	_
25-9	3578-3579	)	_
25-10	3580-3584	were	_
25-11	3585-3591	taking	_
25-12	3592-3605	antipsychotic	_
25-13	3606-3616	medication	_
25-14	3617-3619	at	_
25-15	3620-3623	the	_
25-16	3624-3628	time	_
25-17	3629-3631	of	_
25-18	3632-3639	testing	_
25-19	3640-3641	.	_

Text=HCs were recruited from the community and did not meet criteria for any Axis I diagnosis based on the SCID.
26-1	3642-3645	HCs	http://maven.renci.org/NeuroBridge/neurobridge#Thing
26-2	3646-3650	were	_
26-3	3651-3660	recruited	_
26-4	3661-3665	from	_
26-5	3666-3669	the	_
26-6	3670-3679	community	_
26-7	3680-3683	and	_
26-8	3684-3687	did	_
26-9	3688-3691	not	_
26-10	3692-3696	meet	_
26-11	3697-3705	criteria	_
26-12	3706-3709	for	_
26-13	3710-3713	any	_
26-14	3714-3718	Axis	_
26-15	3719-3720	I	_
26-16	3721-3730	diagnosis	_
26-17	3731-3736	based	_
26-18	3737-3739	on	_
26-19	3740-3743	the	_
26-20	3744-3748	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
26-21	3749-3750	.	_

Text=Written informed consent was obtained from study participants under protocols approved by the Institutional Review Board at UCSF.
27-1	3751-3758	Written	_
27-2	3759-3767	informed	_
27-3	3768-3775	consent	_
27-4	3776-3779	was	_
27-5	3780-3788	obtained	_
27-6	3789-3793	from	_
27-7	3794-3799	study	_
27-8	3800-3812	participants	_
27-9	3813-3818	under	_
27-10	3819-3828	protocols	_
27-11	3829-3837	approved	_
27-12	3838-3840	by	_
27-13	3841-3844	the	_
27-14	3845-3858	Institutional	_
27-15	3859-3865	Review	_
27-16	3866-3871	Board	_
27-17	3872-3874	at	_
27-18	3875-3879	UCSF	_
27-19	3880-3881	.	_

Text=All brain images were acquired on a 3T TIM TRIO scanner at the UCSF Neuroimaging Center.
28-1	3882-3885	All	_
28-2	3886-3891	brain	_
28-3	3892-3898	images	_
28-4	3899-3903	were	_
28-5	3904-3912	acquired	_
28-6	3913-3915	on	_
28-7	3916-3917	a	_
28-8	3918-3920	3T	http://maven.renci.org/NeuroBridge/neurobridge#ConnersRatingScaleRevised
28-9	3921-3924	TIM	http://maven.renci.org/NeuroBridge/neurobridge#ConnersRatingScaleRevised
28-10	3925-3929	TRIO	http://maven.renci.org/NeuroBridge/neurobridge#ConnersRatingScaleRevised
28-11	3930-3937	scanner	http://maven.renci.org/NeuroBridge/neurobridge#ConnersRatingScaleRevised
28-12	3938-3940	at	_
28-13	3941-3944	the	_
28-14	3945-3949	UCSF	_
28-15	3950-3962	Neuroimaging	_
28-16	3963-3969	Center	_
28-17	3970-3971	.	_

Text=Resting-state scans were acquired using high-speed whole-brain echo-planar imaging (EPI) sequences.
29-1	3972-3985	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
29-2	3986-3991	scans	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
29-3	3992-3996	were	_
29-4	3997-4005	acquired	_
29-5	4006-4011	using	_
29-6	4012-4022	high-speed	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
29-7	4023-4034	whole-brain	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
29-8	4035-4046	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
29-9	4047-4054	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
29-10	4055-4056	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
29-11	4057-4060	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
29-12	4061-4062	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
29-13	4063-4072	sequences	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
29-14	4073-4074	.	_

Text=Rest scans lasted six minutes, during which 180 functional images were obtained (32 axial slices, 3.5 mm slice thickness, 1.05 mm inter-slice gap, TR = 2 s, TE = 29 ms, flip angle = 75°, FOV = 24 cm, 64 × 64 matrix).
30-1	4075-4079	Rest	_
30-2	4080-4085	scans	_
30-3	4086-4092	lasted	_
30-4	4093-4096	six	_
30-5	4097-4104	minutes	_
30-6	4105-4106	,	_
30-7	4107-4113	during	_
30-8	4114-4119	which	_
30-9	4120-4123	180	_
30-10	4124-4134	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-11	4135-4141	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-12	4142-4146	were	_
30-13	4147-4155	obtained	_
30-14	4156-4157	(	_
30-15	4158-4160	32	_
30-16	4161-4166	axial	_
30-17	4167-4173	slices	_
30-18	4174-4175	,	_
30-19	4176-4179	3.5	_
30-20	4180-4182	mm	_
30-21	4183-4188	slice	_
30-22	4189-4198	thickness	_
30-23	4199-4200	,	_
30-24	4201-4205	1.05	_
30-25	4206-4208	mm	_
30-26	4209-4220	inter-slice	_
30-27	4221-4224	gap	_
30-28	4225-4226	,	_
30-29	4227-4229	TR	_
30-30	4230-4231	=	_
30-31	4232-4233	2	_
30-32	4234-4235	s	_
30-33	4236-4237	,	_
30-34	4238-4240	TE	_
30-35	4241-4242	=	_
30-36	4243-4245	29	_
30-37	4246-4248	ms	_
30-38	4249-4250	,	_
30-39	4251-4255	flip	_
30-40	4256-4261	angle	_
30-41	4262-4263	=	_
30-42	4264-4267	75°	_
30-43	4268-4269	,	_
30-44	4270-4273	FOV	_
30-45	4274-4275	=	_
30-46	4276-4278	24	_
30-47	4279-4281	cm	_
30-48	4282-4283	,	_
30-49	4284-4286	64	_
30-50	4287-4288	×	_
30-51	4289-4291	64	_
30-52	4292-4298	matrix	_
30-53	4299-4300	)	_
30-54	4301-4302	.	_

Text=Participants were instructed to rest with eyes closed and stay awake.
31-1	4303-4315	Participants	_
31-2	4316-4320	were	_
31-3	4321-4331	instructed	_
31-4	4332-4334	to	_
31-5	4335-4339	rest	_
31-6	4340-4344	with	_
31-7	4345-4349	eyes	_
31-8	4350-4356	closed	_
31-9	4357-4360	and	_
31-10	4361-4365	stay	_
31-11	4366-4371	awake	_
31-12	4372-4373	.	_

Text=FMRI data of each subject were preprocessed using the Data Processing Assistant for Resting-State fMRI (DPARSF) toolbox based on Statistical Parametric Mapping (SPM8) (http: //www.fil.ion.ucl.ac.uk/spm).
32-1	4374-4378	FMRI	_
32-2	4379-4383	data	_
32-3	4384-4386	of	_
32-4	4387-4391	each	_
32-5	4392-4399	subject	_
32-6	4400-4404	were	_
32-7	4405-4417	preprocessed	_
32-8	4418-4423	using	_
32-9	4424-4427	the	_
32-10	4428-4432	Data	_
32-11	4433-4443	Processing	_
32-12	4444-4453	Assistant	_
32-13	4454-4457	for	_
32-14	4458-4471	Resting-State	_
32-15	4472-4476	fMRI	_
32-16	4477-4478	(	_
32-17	4479-4485	DPARSF	_
32-18	4486-4487	)	_
32-19	4488-4495	toolbox	_
32-20	4496-4501	based	_
32-21	4502-4504	on	_
32-22	4505-4516	Statistical	_
32-23	4517-4527	Parametric	_
32-24	4528-4535	Mapping	_
32-25	4536-4537	(	_
32-26	4538-4542	SPM8	_
32-27	4543-4544	)	_
32-28	4545-4546	(	_
32-29	4547-4551	http	_
32-30	4552-4553	:	_
32-31	4554-4581	//www.fil.ion.ucl.ac.uk/spm	_
32-32	4582-4583	)	_
32-33	4584-4585	.	_

Text=The first 10 volumes were discarded, and then the remaining images were slice-time corrected and realigned for head-motion correction.
33-1	4586-4589	The	_
33-2	4590-4595	first	_
33-3	4596-4598	10	_
33-4	4599-4606	volumes	_
33-5	4607-4611	were	_
33-6	4612-4621	discarded	_
33-7	4622-4623	,	_
33-8	4624-4627	and	_
33-9	4628-4632	then	_
33-10	4633-4636	the	_
33-11	4637-4646	remaining	_
33-12	4647-4653	images	_
33-13	4654-4658	were	_
33-14	4659-4669	slice-time	_
33-15	4670-4679	corrected	_
33-16	4680-4683	and	_
33-17	4684-4693	realigned	_
33-18	4694-4697	for	_
33-19	4698-4709	head-motion	_
33-20	4710-4720	correction	_
33-21	4721-4722	.	_

Text=For each subject, the translation of head motion was less than 4 mm and the rotation of head motion did not exceed 4 degrees in all axes through the whole scanning process.
34-1	4723-4726	For	_
34-2	4727-4731	each	_
34-3	4732-4739	subject	_
34-4	4740-4741	,	_
34-5	4742-4745	the	_
34-6	4746-4757	translation	_
34-7	4758-4760	of	_
34-8	4761-4765	head	_
34-9	4766-4772	motion	_
34-10	4773-4776	was	_
34-11	4777-4781	less	_
34-12	4782-4786	than	_
34-13	4787-4788	4	_
34-14	4789-4791	mm	_
34-15	4792-4795	and	_
34-16	4796-4799	the	_
34-17	4800-4808	rotation	_
34-18	4809-4811	of	_
34-19	4812-4816	head	_
34-20	4817-4823	motion	_
34-21	4824-4827	did	_
34-22	4828-4831	not	_
34-23	4832-4838	exceed	_
34-24	4839-4840	4	_
34-25	4841-4848	degrees	_
34-26	4849-4851	in	_
34-27	4852-4855	all	_
34-28	4856-4860	axes	_
34-29	4861-4868	through	_
34-30	4869-4872	the	_
34-31	4873-4878	whole	_
34-32	4879-4887	scanning	_
34-33	4888-4895	process	_
34-34	4896-4897	.	_

Text=The mean and standard deviation of the summarized head motion measures across subjects are reported for each group in Table 1.
35-1	4898-4901	The	_
35-2	4902-4906	mean	_
35-3	4907-4910	and	_
35-4	4911-4919	standard	_
35-5	4920-4929	deviation	_
35-6	4930-4932	of	_
35-7	4933-4936	the	_
35-8	4937-4947	summarized	_
35-9	4948-4952	head	_
35-10	4953-4959	motion	_
35-11	4960-4968	measures	_
35-12	4969-4975	across	_
35-13	4976-4984	subjects	_
35-14	4985-4988	are	_
35-15	4989-4997	reported	_
35-16	4998-5001	for	_
35-17	5002-5006	each	_
35-18	5007-5012	group	_
35-19	5013-5015	in	_
35-20	5016-5021	Table	_
35-21	5022-5023	1	_
35-22	5024-5025	.	_

Text=Analysis of variance (p <0.05) showed no significant group difference in either the maximum translation motion displacement or the maximum rotation motion displacement.
36-1	5026-5034	Analysis	_
36-2	5035-5037	of	_
36-3	5038-5046	variance	_
36-4	5047-5048	(	_
36-5	5049-5050	p	_
36-6	5051-5052	<	_
36-7	5053-5057	0.05	_
36-8	5058-5059	)	_
36-9	5060-5066	showed	_
36-10	5067-5069	no	_
36-11	5070-5081	significant	_
36-12	5082-5087	group	_
36-13	5088-5098	difference	_
36-14	5099-5101	in	_
36-15	5102-5108	either	_
36-16	5109-5112	the	_
36-17	5113-5120	maximum	_
36-18	5121-5132	translation	_
36-19	5133-5139	motion	_
36-20	5140-5152	displacement	_
36-21	5153-5155	or	_
36-22	5156-5159	the	_
36-23	5160-5167	maximum	_
36-24	5168-5176	rotation	_
36-25	5177-5183	motion	_
36-26	5184-5196	displacement	_
36-27	5197-5198	.	_

Text=Subsequently, the images were spatially normalized to the Montreal Neurological Institute (MNI) EPI template, resliced to 3 mm × 3 mm × 3 mm voxels, and smoothed with a Gaussian kernel with a full-width at half-maximum (FWHM) of 6 mm.
37-1	5199-5211	Subsequently	_
37-2	5212-5213	,	_
37-3	5214-5217	the	_
37-4	5218-5224	images	_
37-5	5225-5229	were	_
37-6	5230-5239	spatially	_
37-7	5240-5250	normalized	_
37-8	5251-5253	to	_
37-9	5254-5257	the	_
37-10	5258-5266	Montreal	_
37-11	5267-5279	Neurological	_
37-12	5280-5289	Institute	_
37-13	5290-5291	(	_
37-14	5292-5295	MNI	_
37-15	5296-5297	)	_
37-16	5298-5301	EPI	_
37-17	5302-5310	template	_
37-18	5311-5312	,	_
37-19	5313-5321	resliced	_
37-20	5322-5324	to	_
37-21	5325-5326	3	_
37-22	5327-5329	mm	_
37-23	5330-5331	×	_
37-24	5332-5333	3	_
37-25	5334-5336	mm	_
37-26	5337-5338	×	_
37-27	5339-5340	3	_
37-28	5341-5343	mm	_
37-29	5344-5350	voxels	_
37-30	5351-5352	,	_
37-31	5353-5356	and	_
37-32	5357-5365	smoothed	_
37-33	5366-5370	with	_
37-34	5371-5372	a	_
37-35	5373-5381	Gaussian	_
37-36	5382-5388	kernel	_
37-37	5389-5393	with	_
37-38	5394-5395	a	_
37-39	5396-5406	full-width	_
37-40	5407-5409	at	_
37-41	5410-5422	half-maximum	_
37-42	5423-5424	(	_
37-43	5425-5429	FWHM	_
37-44	5430-5431	)	_
37-45	5432-5434	of	_
37-46	5435-5436	6	_
37-47	5437-5439	mm	_
37-48	5440-5441	.	_

Text=Detrending and band-pass filtering (0.01Hz–0.08Hz) were then performed to remove higher frequency physiological noise and lower frequency scanner drift.
38-1	5442-5452	Detrending	_
38-2	5453-5456	and	_
38-3	5457-5466	band-pass	_
38-4	5467-5476	filtering	_
38-5	5477-5478	(	_
38-6	5479-5492	0.01Hz–0.08Hz	_
38-7	5493-5494	)	_
38-8	5495-5499	were	_
38-9	5500-5504	then	_
38-10	5505-5514	performed	_
38-11	5515-5517	to	_
38-12	5518-5524	remove	_
38-13	5525-5531	higher	_
38-14	5532-5541	frequency	_
38-15	5542-5555	physiological	_
38-16	5556-5561	noise	_
38-17	5562-5565	and	_
38-18	5566-5571	lower	_
38-19	5572-5581	frequency	_
38-20	5582-5589	scanner	_
38-21	5590-5595	drift	_
38-22	5596-5597	.	_

Text=Finally, nuisance covariates including six head motion parameters, white matter signal, cerebrospinal fluid signal, and global mean signal were regressed out, and then residual images were saved for subsequent analyses.
39-1	5598-5605	Finally	_
39-2	5606-5607	,	_
39-3	5608-5616	nuisance	_
39-4	5617-5627	covariates	_
39-5	5628-5637	including	_
39-6	5638-5641	six	_
39-7	5642-5646	head	_
39-8	5647-5653	motion	_
39-9	5654-5664	parameters	_
39-10	5665-5666	,	_
39-11	5667-5672	white	_
39-12	5673-5679	matter	_
39-13	5680-5686	signal	_
39-14	5687-5688	,	_
39-15	5689-5702	cerebrospinal	_
39-16	5703-5708	fluid	_
39-17	5709-5715	signal	_
39-18	5716-5717	,	_
39-19	5718-5721	and	_
39-20	5722-5728	global	_
39-21	5729-5733	mean	_
39-22	5734-5740	signal	_
39-23	5741-5745	were	_
39-24	5746-5755	regressed	_
39-25	5756-5759	out	_
39-26	5760-5761	,	_
39-27	5762-5765	and	_
39-28	5766-5770	then	_
39-29	5771-5779	residual	_
39-30	5780-5786	images	_
39-31	5787-5791	were	_
39-32	5792-5797	saved	_
39-33	5798-5801	for	_
39-34	5802-5812	subsequent	_
39-35	5813-5821	analyses	_
39-36	5822-5823	.	_

Text=Note: the white matter signal, cerebrospinal fluid signal and global mean signal used as covariates were obtained after the detrending and band-pass filtering processing.
40-1	5824-5828	Note	_
40-2	5829-5830	:	_
40-3	5831-5834	the	_
40-4	5835-5840	white	_
40-5	5841-5847	matter	_
40-6	5848-5854	signal	_
40-7	5855-5856	,	_
40-8	5857-5870	cerebrospinal	_
40-9	5871-5876	fluid	_
40-10	5877-5883	signal	_
40-11	5884-5887	and	_
40-12	5888-5894	global	_
40-13	5895-5899	mean	_
40-14	5900-5906	signal	_
40-15	5907-5911	used	_
40-16	5912-5914	as	_
40-17	5915-5925	covariates	_
40-18	5926-5930	were	_
40-19	5931-5939	obtained	_
40-20	5940-5945	after	_
40-21	5946-5949	the	_
40-22	5950-5960	detrending	_
40-23	5961-5964	and	_
40-24	5965-5974	band-pass	_
40-25	5975-5984	filtering	_
40-26	5985-5995	processing	_
40-27	5996-5997	.	_

Text=2.2.
41-1	5998-6001	2.2	_
41-2	6002-6003	.	_

Text=Methods Firstly, time-varying functional connectivity was estimated using a sliding time-window method, and then inherent connectivity states can be computed using our proposed decomposition-based method.
42-1	6004-6011	Methods	_
42-2	6012-6019	Firstly	_
42-3	6020-6021	,	_
42-4	6022-6034	time-varying	_
42-5	6035-6045	functional	_
42-6	6046-6058	connectivity	_
42-7	6059-6062	was	_
42-8	6063-6072	estimated	_
42-9	6073-6078	using	_
42-10	6079-6080	a	_
42-11	6081-6088	sliding	_
42-12	6089-6100	time-window	_
42-13	6101-6107	method	_
42-14	6108-6109	,	_
42-15	6110-6113	and	_
42-16	6114-6118	then	_
42-17	6119-6127	inherent	_
42-18	6128-6140	connectivity	_
42-19	6141-6147	states	_
42-20	6148-6151	can	_
42-21	6152-6154	be	_
42-22	6155-6163	computed	_
42-23	6164-6169	using	_
42-24	6170-6173	our	_
42-25	6174-6182	proposed	_
42-26	6183-6202	decomposition-based	_
42-27	6203-6209	method	_
42-28	6210-6211	.	_

Text=The overall framework of estimating dynamic connectivity and connectivity states is shown in Fig.
43-1	6212-6215	The	_
43-2	6216-6223	overall	_
43-3	6224-6233	framework	_
43-4	6234-6236	of	_
43-5	6237-6247	estimating	_
43-6	6248-6255	dynamic	_
43-7	6256-6268	connectivity	_
43-8	6269-6272	and	_
43-9	6273-6285	connectivity	_
43-10	6286-6292	states	_
43-11	6293-6295	is	_
43-12	6296-6301	shown	_
43-13	6302-6304	in	_
43-14	6305-6308	Fig	_
43-15	6309-6310	.	_

Text=1.
44-1	6311-6312	1	_
44-2	6313-6314	.	_

Text=Detailed procedures are explained in the following subsections.
45-1	6315-6323	Detailed	_
45-2	6324-6334	procedures	_
45-3	6335-6338	are	_
45-4	6339-6348	explained	_
45-5	6349-6351	in	_
45-6	6352-6355	the	_
45-7	6356-6365	following	_
45-8	6366-6377	subsections	_
45-9	6378-6379	.	_

Text=Finally, we investigated group differences based on the individual-subject ’ s connectivity states, aiming to reveal potential biomarkers.
46-1	6380-6387	Finally	_
46-2	6388-6389	,	_
46-3	6390-6392	we	_
46-4	6393-6405	investigated	_
46-5	6406-6411	group	_
46-6	6412-6423	differences	_
46-7	6424-6429	based	_
46-8	6430-6432	on	_
46-9	6433-6436	the	_
46-10	6437-6455	individual-subject	_
46-11	6456-6457	’	_
46-12	6458-6459	s	_
46-13	6460-6472	connectivity	_
46-14	6473-6479	states	_
46-15	6480-6481	,	_
46-16	6482-6488	aiming	_
46-17	6489-6491	to	_
46-18	6492-6498	reveal	_
46-19	6499-6508	potential	_
46-20	6509-6519	biomarkers	_
46-21	6520-6521	.	_

Text=2.2.1.
47-1	6522-6527	2.2.1	http://maven.renci.org/NeuroBridge/neurobridge#Thing
47-2	6528-6529	.	http://maven.renci.org/NeuroBridge/neurobridge#Thing

Text=Estimating dynamic functional connectivity As shown in Fig.
48-1	6530-6540	Estimating	_
48-2	6541-6548	dynamic	_
48-3	6549-6559	functional	_
48-4	6560-6572	connectivity	_
48-5	6573-6575	As	_
48-6	6576-6581	shown	_
48-7	6582-6584	in	_
48-8	6585-6588	Fig	_
48-9	6589-6590	.	_

Text=1A, using the sliding time-window method, we computed whole-brain DFC for each subject based on 116 ROIs from the automated anatomical labeling (AAL) template.
49-1	6591-6593	1A	_
49-2	6594-6595	,	_
49-3	6596-6601	using	_
49-4	6602-6605	the	_
49-5	6606-6613	sliding	_
49-6	6614-6625	time-window	_
49-7	6626-6632	method	_
49-8	6633-6634	,	_
49-9	6635-6637	we	_
49-10	6638-6646	computed	_
49-11	6647-6658	whole-brain	_
49-12	6659-6662	DFC	_
49-13	6663-6666	for	_
49-14	6667-6671	each	_
49-15	6672-6679	subject	_
49-16	6680-6685	based	_
49-17	6686-6688	on	_
49-18	6689-6692	116	_
49-19	6693-6697	ROIs	_
49-20	6698-6702	from	_
49-21	6703-6706	the	_
49-22	6707-6716	automated	_
49-23	6717-6727	anatomical	_
49-24	6728-6736	labeling	_
49-25	6737-6738	(	_
49-26	6739-6742	AAL	_
49-27	6743-6744	)	_
49-28	6745-6753	template	_
49-29	6754-6755	.	_

Text=The index (ID) and name of each ROI can be found in supplementary Table S2.
50-1	6756-6759	The	_
50-2	6760-6765	index	_
50-3	6766-6767	(	_
50-4	6768-6770	ID	_
50-5	6771-6772	)	_
50-6	6773-6776	and	_
50-7	6777-6781	name	_
50-8	6782-6784	of	_
50-9	6785-6789	each	_
50-10	6790-6793	ROI	_
50-11	6794-6797	can	_
50-12	6798-6800	be	_
50-13	6801-6806	found	_
50-14	6807-6809	in	_
50-15	6810-6823	supplementary	_
50-16	6824-6829	Table	_
50-17	6830-6832	S2	_
50-18	6833-6834	.	_

Text=For the averaged time-series within each ROI, we segmented it using a sliding time-window that was created by convolving a rectangle (width = 20 TRs) with a Gaussian (σ = 3 TRs).
51-1	6835-6838	For	_
51-2	6839-6842	the	_
51-3	6843-6851	averaged	_
51-4	6852-6863	time-series	_
51-5	6864-6870	within	_
51-6	6871-6875	each	_
51-7	6876-6879	ROI	_
51-8	6880-6881	,	_
51-9	6882-6884	we	_
51-10	6885-6894	segmented	_
51-11	6895-6897	it	_
51-12	6898-6903	using	_
51-13	6904-6905	a	_
51-14	6906-6913	sliding	_
51-15	6914-6925	time-window	_
51-16	6926-6930	that	_
51-17	6931-6934	was	_
51-18	6935-6942	created	_
51-19	6943-6945	by	_
51-20	6946-6956	convolving	_
51-21	6957-6958	a	_
51-22	6959-6968	rectangle	_
51-23	6969-6970	(	_
51-24	6971-6976	width	_
51-25	6977-6978	=	_
51-26	6979-6981	20	_
51-27	6982-6985	TRs	_
51-28	6986-6987	)	_
51-29	6988-6992	with	_
51-30	6993-6994	a	_
51-31	6995-7003	Gaussian	_
51-32	7004-7005	(	_
51-33	7006-7007	σ	_
51-34	7008-7009	=	_
51-35	7010-7011	3	_
51-36	7012-7015	TRs	_
51-37	7016-7017	)	_
51-38	7018-7019	.	_

Text=The window length was 40 s (2 s × 20), which has extensively evaluated and shown to be suitable for capturing dynamics in FCs.
52-1	7020-7023	The	_
52-2	7024-7030	window	_
52-3	7031-7037	length	_
52-4	7038-7041	was	_
52-5	7042-7044	40	_
52-6	7045-7046	s	_
52-7	7047-7048	(	_
52-8	7049-7050	2	_
52-9	7051-7052	s	_
52-10	7053-7054	×	_
52-11	7055-7057	20	_
52-12	7058-7059	)	_
52-13	7060-7061	,	_
52-14	7062-7067	which	_
52-15	7068-7071	has	_
52-16	7072-7083	extensively	_
52-17	7084-7093	evaluated	_
52-18	7094-7097	and	_
52-19	7098-7103	shown	_
52-20	7104-7106	to	_
52-21	7107-7109	be	_
52-22	7110-7118	suitable	_
52-23	7119-7122	for	_
52-24	7123-7132	capturing	_
52-25	7133-7141	dynamics	_
52-26	7142-7144	in	_
52-27	7145-7148	FCs	_
52-28	7149-7150	.	_

Text=The window slid in steps of 1 TR, resulting in 151 short time-series for each ROI.
53-1	7151-7154	The	_
53-2	7155-7161	window	_
53-3	7162-7166	slid	_
53-4	7167-7169	in	_
53-5	7170-7175	steps	_
53-6	7176-7178	of	_
53-7	7179-7180	1	_
53-8	7181-7183	TR	_
53-9	7184-7185	,	_
53-10	7186-7195	resulting	_
53-11	7196-7198	in	_
53-12	7199-7202	151	_
53-13	7203-7208	short	_
53-14	7209-7220	time-series	_
53-15	7221-7224	for	_
53-16	7225-7229	each	_
53-17	7230-7233	ROI	_
53-18	7234-7235	.	_

Text=Afterwards, regarding each window, a 116 × 116 connectivity matrix was calculated based on the associated short time-series of all ROIs.
54-1	7236-7246	Afterwards	_
54-2	7247-7248	,	_
54-3	7249-7258	regarding	_
54-4	7259-7263	each	_
54-5	7264-7270	window	_
54-6	7271-7272	,	_
54-7	7273-7274	a	_
54-8	7275-7278	116	_
54-9	7279-7280	×	_
54-10	7281-7284	116	_
54-11	7285-7297	connectivity	_
54-12	7298-7304	matrix	_
54-13	7305-7308	was	_
54-14	7309-7319	calculated	_
54-15	7320-7325	based	_
54-16	7326-7328	on	_
54-17	7329-7332	the	_
54-18	7333-7343	associated	_
54-19	7344-7349	short	_
54-20	7350-7361	time-series	_
54-21	7362-7364	of	_
54-22	7365-7368	all	_
54-23	7369-7373	ROIs	_
54-24	7374-7375	.	_

Text=Each connectivity matrix reflecting the temporal correlations among ROIs within one window was estimated from a regularized inverse covariance matrix using a graphical LASSO framework.
55-1	7376-7380	Each	_
55-2	7381-7393	connectivity	_
55-3	7394-7400	matrix	_
55-4	7401-7411	reflecting	_
55-5	7412-7415	the	_
55-6	7416-7424	temporal	_
55-7	7425-7437	correlations	_
55-8	7438-7443	among	_
55-9	7444-7448	ROIs	_
55-10	7449-7455	within	_
55-11	7456-7459	one	_
55-12	7460-7466	window	_
55-13	7467-7470	was	_
55-14	7471-7480	estimated	_
55-15	7481-7485	from	_
55-16	7486-7487	a	_
55-17	7488-7499	regularized	_
55-18	7500-7507	inverse	_
55-19	7508-7518	covariance	_
55-20	7519-7525	matrix	_
55-21	7526-7531	using	_
55-22	7532-7533	a	_
55-23	7534-7543	graphical	_
55-24	7544-7549	LASSO	_
55-25	7550-7559	framework	_
55-26	7560-7561	.	_

Text=LASSO imposed sparsity by placing an L1 norm penalty on the inverse covariance matrix to decrease noise effect of short time series.
56-1	7562-7567	LASSO	_
56-2	7568-7575	imposed	_
56-3	7576-7584	sparsity	_
56-4	7585-7587	by	_
56-5	7588-7595	placing	_
56-6	7596-7598	an	_
56-7	7599-7601	L1	_
56-8	7602-7606	norm	_
56-9	7607-7614	penalty	_
56-10	7615-7617	on	_
56-11	7618-7621	the	_
56-12	7622-7629	inverse	_
56-13	7630-7640	covariance	_
56-14	7641-7647	matrix	_
56-15	7648-7650	to	_
56-16	7651-7659	decrease	_
56-17	7660-7665	noise	_
56-18	7666-7672	effect	_
56-19	7673-7675	of	_
56-20	7676-7681	short	_
56-21	7682-7686	time	_
56-22	7687-7693	series	_
56-23	7694-7695	.	_

Text=After obtaining the regularized inverse covariance matrix, its corresponding covariance matrix was calculated and then transformed into a correlation matrix, representing the functional connectivity matrix.
57-1	7696-7701	After	_
57-2	7702-7711	obtaining	_
57-3	7712-7715	the	_
57-4	7716-7727	regularized	_
57-5	7728-7735	inverse	_
57-6	7736-7746	covariance	_
57-7	7747-7753	matrix	_
57-8	7754-7755	,	_
57-9	7756-7759	its	_
57-10	7760-7773	corresponding	_
57-11	7774-7784	covariance	_
57-12	7785-7791	matrix	_
57-13	7792-7795	was	_
57-14	7796-7806	calculated	_
57-15	7807-7810	and	_
57-16	7811-7815	then	_
57-17	7816-7827	transformed	_
57-18	7828-7832	into	_
57-19	7833-7834	a	_
57-20	7835-7846	correlation	_
57-21	7847-7853	matrix	_
57-22	7854-7855	,	_
57-23	7856-7868	representing	_
57-24	7869-7872	the	_
57-25	7873-7883	functional	_
57-26	7884-7896	connectivity	_
57-27	7897-7903	matrix	_
57-28	7904-7905	.	_

Text=Thus, for each subject, 151 connectivity matrices were obtained, reflecting time-varying functional connectivity between paired ROIs.
58-1	7906-7910	Thus	_
58-2	7911-7912	,	_
58-3	7913-7916	for	_
58-4	7917-7921	each	_
58-5	7922-7929	subject	_
58-6	7930-7931	,	_
58-7	7932-7935	151	_
58-8	7936-7948	connectivity	_
58-9	7949-7957	matrices	_
58-10	7958-7962	were	_
58-11	7963-7971	obtained	_
58-12	7972-7973	,	_
58-13	7974-7984	reflecting	_
58-14	7985-7997	time-varying	_
58-15	7998-8008	functional	_
58-16	8009-8021	connectivity	_
58-17	8022-8029	between	_
58-18	8030-8036	paired	_
58-19	8037-8041	ROIs	_
58-20	8042-8043	.	_

Text=Due to the symmetry of connectivity matrix within each window, the upper half 6670 unique elements can reflect connectivity strengths among 116 ROIs.
59-1	8044-8047	Due	_
59-2	8048-8050	to	_
59-3	8051-8054	the	_
59-4	8055-8063	symmetry	_
59-5	8064-8066	of	_
59-6	8067-8079	connectivity	_
59-7	8080-8086	matrix	_
59-8	8087-8093	within	_
59-9	8094-8098	each	_
59-10	8099-8105	window	_
59-11	8106-8107	,	_
59-12	8108-8111	the	_
59-13	8112-8117	upper	_
59-14	8118-8122	half	_
59-15	8123-8127	6670	_
59-16	8128-8134	unique	_
59-17	8135-8143	elements	_
59-18	8144-8147	can	_
59-19	8148-8155	reflect	_
59-20	8156-8168	connectivity	_
59-21	8169-8178	strengths	_
59-22	8179-8184	among	_
59-23	8185-8188	116	_
59-24	8189-8193	ROIs	_
59-25	8194-8195	.	_

Text=Taking the kth subject for an example, its dynamic connectivity can be denoted by a window-by-connectivity matrix Xk (size: 151 × 6670).
60-1	8196-8202	Taking	_
60-2	8203-8206	the	_
60-3	8207-8210	kth	_
60-4	8211-8218	subject	_
60-5	8219-8222	for	_
60-6	8223-8225	an	_
60-7	8226-8233	example	_
60-8	8234-8235	,	_
60-9	8236-8239	its	_
60-10	8240-8247	dynamic	_
60-11	8248-8260	connectivity	_
60-12	8261-8264	can	_
60-13	8265-8267	be	_
60-14	8268-8275	denoted	_
60-15	8276-8278	by	_
60-16	8279-8280	a	_
60-17	8281-8303	window-by-connectivity	_
60-18	8304-8310	matrix	_
60-19	8311-8313	Xk	_
60-20	8314-8315	(	_
60-21	8316-8320	size	_
60-22	8321-8322	:	_
60-23	8323-8326	151	_
60-24	8327-8328	×	_
60-25	8329-8333	6670	_
60-26	8334-8335	)	_
60-27	8336-8337	.	_

Text=We then performed a r-to-z Fisher transformation on Xk.
61-1	8338-8340	We	_
61-2	8341-8345	then	_
61-3	8346-8355	performed	_
61-4	8356-8357	a	_
61-5	8358-8364	r-to-z	_
61-6	8365-8371	Fisher	_
61-7	8372-8386	transformation	_
61-8	8387-8389	on	_
61-9	8390-8392	Xk	_
61-10	8393-8394	.	_

Text=2.2.2.
62-1	8395-8400	2.2.2	_
62-2	8401-8402	.	_

Text=Estimating functional connectivity states Previous work has shown that multiple connectivity states exist in the time-varying connectivity.
63-1	8403-8413	Estimating	_
63-2	8414-8424	functional	_
63-3	8425-8437	connectivity	_
63-4	8438-8444	states	_
63-5	8445-8453	Previous	_
63-6	8454-8458	work	_
63-7	8459-8462	has	_
63-8	8463-8468	shown	_
63-9	8469-8473	that	_
63-10	8474-8482	multiple	_
63-11	8483-8495	connectivity	_
63-12	8496-8502	states	_
63-13	8503-8508	exist	_
63-14	8509-8511	in	_
63-15	8512-8515	the	_
63-16	8516-8528	time-varying	_
63-17	8529-8541	connectivity	_
63-18	8542-8543	.	_

Text=In the study, we sought to investigate whether HC, CHR and ESZ groups showed differences in the connectivity states; and if true, whether these changes showed a progressive trend from the healthy condition to psychosis risk to early schizophrenia.
64-1	8544-8546	In	_
64-2	8547-8550	the	_
64-3	8551-8556	study	_
64-4	8557-8558	,	_
64-5	8559-8561	we	_
64-6	8562-8568	sought	_
64-7	8569-8571	to	_
64-8	8572-8583	investigate	_
64-9	8584-8591	whether	_
64-10	8592-8594	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
64-11	8595-8596	,	_
64-12	8597-8600	CHR	http://maven.renci.org/NeuroBridge/neurobridge#ChronicPain
64-13	8601-8604	and	_
64-14	8605-8608	ESZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
64-15	8609-8615	groups	_
64-16	8616-8622	showed	_
64-17	8623-8634	differences	_
64-18	8635-8637	in	_
64-19	8638-8641	the	_
64-20	8642-8654	connectivity	_
64-21	8655-8661	states	_
64-22	8662-8663	;	_
64-23	8664-8667	and	_
64-24	8668-8670	if	_
64-25	8671-8675	true	_
64-26	8676-8677	,	_
64-27	8678-8685	whether	_
64-28	8686-8691	these	_
64-29	8692-8699	changes	_
64-30	8700-8706	showed	_
64-31	8707-8708	a	_
64-32	8709-8720	progressive	_
64-33	8721-8726	trend	_
64-34	8727-8731	from	_
64-35	8732-8735	the	_
64-36	8736-8743	healthy	_
64-37	8744-8753	condition	_
64-38	8754-8756	to	_
64-39	8757-8766	psychosis	_
64-40	8767-8771	risk	_
64-41	8772-8774	to	_
64-42	8775-8780	early	_
64-43	8781-8794	schizophrenia	_
64-44	8795-8796	.	_

Text=Our recently proposed dynamic connectivity analysis method was applied to estimate the connectivity states.
65-1	8797-8800	Our	_
65-2	8801-8809	recently	_
65-3	8810-8818	proposed	_
65-4	8819-8826	dynamic	_
65-5	8827-8839	connectivity	_
65-6	8840-8848	analysis	_
65-7	8849-8855	method	_
65-8	8856-8859	was	_
65-9	8860-8867	applied	_
65-10	8868-8870	to	_
65-11	8871-8879	estimate	_
65-12	8880-8883	the	_
65-13	8884-8896	connectivity	_
65-14	8897-8903	states	_
65-15	8904-8905	.	_

Text=In our method, the connectivity states are decoded by the independent components (ICs), and the loadings of ICs represent the fluctuations of connectivity states.
66-1	8906-8908	In	_
66-2	8909-8912	our	_
66-3	8913-8919	method	_
66-4	8920-8921	,	_
66-5	8922-8925	the	_
66-6	8926-8938	connectivity	_
66-7	8939-8945	states	_
66-8	8946-8949	are	_
66-9	8950-8957	decoded	_
66-10	8958-8960	by	_
66-11	8961-8964	the	_
66-12	8965-8976	independent	_
66-13	8977-8987	components	_
66-14	8988-8989	(	_
66-15	8990-8993	ICs	_
66-16	8994-8995	)	_
66-17	8996-8997	,	_
66-18	8998-9001	and	_
66-19	9002-9005	the	_
66-20	9006-9014	loadings	_
66-21	9015-9017	of	_
66-22	9018-9021	ICs	_
66-23	9022-9031	represent	_
66-24	9032-9035	the	_
66-25	9036-9048	fluctuations	_
66-26	9049-9051	of	_
66-27	9052-9064	connectivity	_
66-28	9065-9071	states	_
66-29	9072-9073	.	_

Text=Considering there are probably connectivity states with group-specific patterns among the three groups, we extracted connectivity states for each group.
67-1	9074-9085	Considering	_
67-2	9086-9091	there	_
67-3	9092-9095	are	_
67-4	9096-9104	probably	_
67-5	9105-9117	connectivity	_
67-6	9118-9124	states	_
67-7	9125-9129	with	_
67-8	9130-9144	group-specific	_
67-9	9145-9153	patterns	_
67-10	9154-9159	among	_
67-11	9160-9163	the	_
67-12	9164-9169	three	_
67-13	9170-9176	groups	_
67-14	9177-9178	,	_
67-15	9179-9181	we	_
67-16	9182-9191	extracted	_
67-17	9192-9204	connectivity	_
67-18	9205-9211	states	_
67-19	9212-9215	for	_
67-20	9216-9220	each	_
67-21	9221-9226	group	_
67-22	9227-9228	.	_

Text=The following processing steps were implemented for each group separately.
68-1	9229-9232	The	_
68-2	9233-9242	following	_
68-3	9243-9253	processing	_
68-4	9254-9259	steps	_
68-5	9260-9264	were	_
68-6	9265-9276	implemented	_
68-7	9277-9280	for	_
68-8	9281-9285	each	_
68-9	9286-9291	group	_
68-10	9292-9302	separately	_
68-11	9303-9304	.	_

Text=We concatenated the window-by-connectivity matrices of all subjects along the window direction and obtained a matrix X= [X1; …; Xk; …; XN], (k = 1, …, N), where N was the number of subjects.
69-1	9305-9307	We	_
69-2	9308-9320	concatenated	_
69-3	9321-9324	the	_
69-4	9325-9347	window-by-connectivity	_
69-5	9348-9356	matrices	_
69-6	9357-9359	of	_
69-7	9360-9363	all	_
69-8	9364-9372	subjects	_
69-9	9373-9378	along	_
69-10	9379-9382	the	_
69-11	9383-9389	window	_
69-12	9390-9399	direction	_
69-13	9400-9403	and	_
69-14	9404-9412	obtained	_
69-15	9413-9414	a	_
69-16	9415-9421	matrix	_
69-17	9422-9424	X=	_
69-18	9425-9426	[	_
69-19	9427-9429	X1	_
69-20	9430-9431	;	_
69-21	9432-9433	…	_
69-22	9434-9435	;	_
69-23	9436-9438	Xk	_
69-24	9439-9440	;	_
69-25	9441-9442	…	_
69-26	9443-9444	;	_
69-27	9445-9447	XN	_
69-28	9448-9449	]	_
69-29	9450-9451	,	_
69-30	9452-9453	(	_
69-31	9454-9455	k	_
69-32	9456-9457	=	_
69-33	9458-9459	1	_
69-34	9460-9461	,	_
69-35	9462-9463	…	_
69-36	9464-9465	,	_
69-37	9466-9467	N	_
69-38	9468-9469	)	_
69-39	9470-9471	,	_
69-40	9472-9477	where	_
69-41	9478-9479	N	_
69-42	9480-9483	was	_
69-43	9484-9487	the	_
69-44	9488-9494	number	_
69-45	9495-9497	of	_
69-46	9498-9506	subjects	_
69-47	9507-9508	.	_

Text=As shown in Fig.
70-1	9509-9511	As	_
70-2	9512-9517	shown	_
70-3	9518-9520	in	_
70-4	9521-9524	Fig	_
70-5	9525-9526	.	_

Text=1B, we performed ICA using ICASSO technique on the whole dynamic connectivity matrix (i.e., X) to compute the reliable group-level connectivity states (GSs).
71-1	9527-9529	1B	_
71-2	9530-9531	,	_
71-3	9532-9534	we	_
71-4	9535-9544	performed	_
71-5	9545-9548	ICA	_
71-6	9549-9554	using	_
71-7	9555-9561	ICASSO	_
71-8	9562-9571	technique	_
71-9	9572-9574	on	_
71-10	9575-9578	the	_
71-11	9579-9584	whole	_
71-12	9585-9592	dynamic	_
71-13	9593-9605	connectivity	_
71-14	9606-9612	matrix	_
71-15	9613-9614	(	_
71-16	9615-9619	i.e.	_
71-17	9620-9621	,	_
71-18	9622-9623	X	_
71-19	9624-9625	)	_
71-20	9626-9628	to	_
71-21	9629-9636	compute	_
71-22	9637-9640	the	_
71-23	9641-9649	reliable	_
71-24	9650-9661	group-level	_
71-25	9662-9674	connectivity	_
71-26	9675-9681	states	_
71-27	9682-9683	(	_
71-28	9684-9687	GSs	_
71-29	9688-9689	)	_
71-30	9690-9691	.	_

Text=Before ICA, subject-level PCAs and a following group-level PCA were used to reduce the dimensionality of the window direction.
72-1	9692-9698	Before	_
72-2	9699-9702	ICA	_
72-3	9703-9704	,	_
72-4	9705-9718	subject-level	_
72-5	9719-9723	PCAs	_
72-6	9724-9727	and	_
72-7	9728-9729	a	_
72-8	9730-9739	following	_
72-9	9740-9751	group-level	_
72-10	9752-9755	PCA	_
72-11	9756-9760	were	_
72-12	9761-9765	used	_
72-13	9766-9768	to	_
72-14	9769-9775	reduce	_
72-15	9776-9779	the	_
72-16	9780-9794	dimensionality	_
72-17	9795-9797	of	_
72-18	9798-9801	the	_
72-19	9802-9808	window	_
72-20	9809-9818	direction	_
72-21	9819-9820	.	_

Text=Thus, we had X = A·S, where S = [S1; …; Sl; …; SM] included all group-level ICs.
73-1	9821-9825	Thus	_
73-2	9826-9827	,	_
73-3	9828-9830	we	_
73-4	9831-9834	had	_
73-5	9835-9836	X	_
73-6	9837-9838	=	_
73-7	9839-9842	A·S	_
73-8	9843-9844	,	_
73-9	9845-9850	where	_
73-10	9851-9852	S	_
73-11	9853-9854	=	_
73-12	9855-9856	[	_
73-13	9857-9859	S1	_
73-14	9860-9861	;	_
73-15	9862-9863	…	_
73-16	9864-9865	;	_
73-17	9866-9868	Sl	_
73-18	9869-9870	;	_
73-19	9871-9872	…	_
73-20	9873-9874	;	_
73-21	9875-9877	SM	_
73-22	9878-9879	]	_
73-23	9880-9888	included	_
73-24	9889-9892	all	_
73-25	9893-9904	group-level	_
73-26	9905-9908	ICs	_
73-27	9909-9910	.	_

Text=Sl can represent information of the lth GS.
74-1	9911-9913	Sl	_
74-2	9914-9917	can	_
74-3	9918-9927	represent	_
74-4	9928-9939	information	_
74-5	9940-9942	of	_
74-6	9943-9946	the	_
74-7	9947-9950	lth	_
74-8	9951-9953	GS	_
74-9	9954-9955	.	_

Text=Although it is hard to determine an optimal setting for the number of components, many prior studies suggested five connectivity states to estimate in dynamic connectivity analysis.
75-1	9956-9964	Although	_
75-2	9965-9967	it	_
75-3	9968-9970	is	_
75-4	9971-9975	hard	_
75-5	9976-9978	to	_
75-6	9979-9988	determine	_
75-7	9989-9991	an	_
75-8	9992-9999	optimal	_
75-9	10000-10007	setting	_
75-10	10008-10011	for	_
75-11	10012-10015	the	_
75-12	10016-10022	number	_
75-13	10023-10025	of	_
75-14	10026-10036	components	_
75-15	10037-10038	,	_
75-16	10039-10043	many	_
75-17	10044-10049	prior	_
75-18	10050-10057	studies	_
75-19	10058-10067	suggested	_
75-20	10068-10072	five	_
75-21	10073-10085	connectivity	_
75-22	10086-10092	states	_
75-23	10093-10095	to	_
75-24	10096-10104	estimate	_
75-25	10105-10107	in	_
75-26	10108-10115	dynamic	_
75-27	10116-10128	connectivity	_
75-28	10129-10137	analysis	_
75-29	10138-10139	.	_

Text=So, consistent to previous work, M was set to 5 in this study.
76-1	10140-10142	So	_
76-2	10143-10144	,	_
76-3	10145-10155	consistent	_
76-4	10156-10158	to	_
76-5	10159-10167	previous	_
76-6	10168-10172	work	_
76-7	10173-10174	,	_
76-8	10175-10176	M	_
76-9	10177-10180	was	_
76-10	10181-10184	set	_
76-11	10185-10187	to	_
76-12	10188-10189	5	_
76-13	10190-10192	in	_
76-14	10193-10197	this	_
76-15	10198-10203	study	_
76-16	10204-10205	.	_

Text=Using this setting, the mean of preserved variances was 76% in subject-level PCAs and reliable performance of ICASSO with 20 ICA runs was achieved (see supplementary Fig.
77-1	10206-10211	Using	_
77-2	10212-10216	this	_
77-3	10217-10224	setting	_
77-4	10225-10226	,	_
77-5	10227-10230	the	_
77-6	10231-10235	mean	_
77-7	10236-10238	of	_
77-8	10239-10248	preserved	_
77-9	10249-10258	variances	_
77-10	10259-10262	was	_
77-11	10263-10265	76	_
77-12	10266-10267	%	_
77-13	10268-10270	in	_
77-14	10271-10284	subject-level	_
77-15	10285-10289	PCAs	_
77-16	10290-10293	and	_
77-17	10294-10302	reliable	_
77-18	10303-10314	performance	_
77-19	10315-10317	of	_
77-20	10318-10324	ICASSO	_
77-21	10325-10329	with	_
77-22	10330-10332	20	_
77-23	10333-10336	ICA	_
77-24	10337-10341	runs	_
77-25	10342-10345	was	_
77-26	10346-10354	achieved	_
77-27	10355-10356	(	_
77-28	10357-10360	see	_
77-29	10361-10374	supplementary	_
77-30	10375-10378	Fig	_
77-31	10379-10380	.	_

Text=S1).
78-1	10381-10383	S1	_
78-2	10384-10385	)	_
78-3	10386-10387	.	_

Text=Each GS (i.e., one row of S) was z-scored to zero mean and unit variance for consequent processing.
79-1	10388-10392	Each	_
79-2	10393-10395	GS	_
79-3	10396-10397	(	_
79-4	10398-10402	i.e.	_
79-5	10403-10404	,	_
79-6	10405-10408	one	_
79-7	10409-10412	row	_
79-8	10413-10415	of	_
79-9	10416-10417	S	_
79-10	10418-10419	)	_
79-11	10420-10423	was	_
79-12	10424-10432	z-scored	_
79-13	10433-10435	to	_
79-14	10436-10440	zero	_
79-15	10441-10445	mean	_
79-16	10446-10449	and	_
79-17	10450-10454	unit	_
79-18	10455-10463	variance	_
79-19	10464-10467	for	_
79-20	10468-10478	consequent	_
79-21	10479-10489	processing	_
79-22	10490-10491	.	_

Text=According to ICA, A= [A1; …; Ak; …; AN] included the mixing coefficient matrices of all subjects.
80-1	10492-10501	According	_
80-2	10502-10504	to	_
80-3	10505-10508	ICA	_
80-4	10509-10510	,	_
80-5	10511-10513	A=	_
80-6	10514-10515	[	_
80-7	10516-10518	A1	_
80-8	10519-10520	;	_
80-9	10521-10522	…	_
80-10	10523-10524	;	_
80-11	10525-10527	Ak	_
80-12	10528-10529	;	_
80-13	10530-10531	…	_
80-14	10532-10533	;	_
80-15	10534-10536	AN	_
80-16	10537-10538	]	_
80-17	10539-10547	included	_
80-18	10548-10551	the	_
80-19	10552-10558	mixing	_
80-20	10559-10570	coefficient	_
80-21	10571-10579	matrices	_
80-22	10580-10582	of	_
80-23	10583-10586	all	_
80-24	10587-10595	subjects	_
80-25	10596-10597	.	_

Text=Ak represented the temporal fluctuations of all connectivity states for the kth subject, and each column of Ak reflected the subject-specific fluctuation (SF) of one state for the kth subject.
81-1	10598-10600	Ak	_
81-2	10601-10612	represented	_
81-3	10613-10616	the	_
81-4	10617-10625	temporal	_
81-5	10626-10638	fluctuations	_
81-6	10639-10641	of	_
81-7	10642-10645	all	_
81-8	10646-10658	connectivity	_
81-9	10659-10665	states	_
81-10	10666-10669	for	_
81-11	10670-10673	the	_
81-12	10674-10677	kth	_
81-13	10678-10685	subject	_
81-14	10686-10687	,	_
81-15	10688-10691	and	_
81-16	10692-10696	each	_
81-17	10697-10703	column	_
81-18	10704-10706	of	_
81-19	10707-10709	Ak	_
81-20	10710-10719	reflected	_
81-21	10720-10723	the	_
81-22	10724-10740	subject-specific	_
81-23	10741-10752	fluctuation	_
81-24	10753-10754	(	_
81-25	10755-10757	SF	_
81-26	10758-10759	)	_
81-27	10760-10762	of	_
81-28	10763-10766	one	_
81-29	10767-10772	state	_
81-30	10773-10776	for	_
81-31	10777-10780	the	_
81-32	10781-10784	kth	_
81-33	10785-10792	subject	_
81-34	10793-10794	.	_

Text=Afterwards, we assessed the contribution of each GS to the dynamic connectivity.
82-1	10795-10805	Afterwards	_
82-2	10806-10807	,	_
82-3	10808-10810	we	_
82-4	10811-10819	assessed	_
82-5	10820-10823	the	_
82-6	10824-10836	contribution	_
82-7	10837-10839	of	_
82-8	10840-10844	each	_
82-9	10845-10847	GS	_
82-10	10848-10850	to	_
82-11	10851-10854	the	_
82-12	10855-10862	dynamic	_
82-13	10863-10875	connectivity	_
82-14	10876-10877	.	_

Text=The contribution of the lth GS was measured using, where al was the lth column of A.
83-1	10878-10881	The	_
83-2	10882-10894	contribution	_
83-3	10895-10897	of	_
83-4	10898-10901	the	_
83-5	10902-10905	lth	_
83-6	10906-10908	GS	_
83-7	10909-10912	was	_
83-8	10913-10921	measured	_
83-9	10922-10927	using	_
83-10	10928-10929	,	_
83-11	10930-10935	where	_
83-12	10936-10938	al	_
83-13	10939-10942	was	_
83-14	10943-10946	the	_
83-15	10947-10950	lth	_
83-16	10951-10957	column	_
83-17	10958-10960	of	_
83-18	10961-10962	A	_
83-19	10963-10964	.	_

Text=The measure reflected the percentage of the loading of each GS in all GSs ’ loading sum.
84-1	10965-10968	The	_
84-2	10969-10976	measure	_
84-3	10977-10986	reflected	_
84-4	10987-10990	the	_
84-5	10991-11001	percentage	_
84-6	11002-11004	of	_
84-7	11005-11008	the	_
84-8	11009-11016	loading	_
84-9	11017-11019	of	_
84-10	11020-11024	each	_
84-11	11025-11027	GS	_
84-12	11028-11030	in	_
84-13	11031-11034	all	_
84-14	11035-11038	GSs	_
84-15	11039-11040	’	_
84-16	11041-11048	loading	_
84-17	11049-11052	sum	_
84-18	11053-11054	.	_

Text=Consequently, the first-rank GS was identified as the dominant GS (e.g., Sl), which included the most information across entire dynamic connectivity stream of all subjects.
85-1	11055-11067	Consequently	_
85-2	11068-11069	,	_
85-3	11070-11073	the	_
85-4	11074-11084	first-rank	_
85-5	11085-11087	GS	_
85-6	11088-11091	was	_
85-7	11092-11102	identified	_
85-8	11103-11105	as	_
85-9	11106-11109	the	_
85-10	11110-11118	dominant	_
85-11	11119-11121	GS	_
85-12	11122-11123	(	_
85-13	11124-11128	e.g.	_
85-14	11129-11130	,	_
85-15	11131-11133	Sl	_
85-16	11134-11135	)	_
85-17	11136-11137	,	_
85-18	11138-11143	which	_
85-19	11144-11152	included	_
85-20	11153-11156	the	_
85-21	11157-11161	most	_
85-22	11162-11173	information	_
85-23	11174-11180	across	_
85-24	11181-11187	entire	_
85-25	11188-11195	dynamic	_
85-26	11196-11208	connectivity	_
85-27	11209-11215	stream	_
85-28	11216-11218	of	_
85-29	11219-11222	all	_
85-30	11223-11231	subjects	_
85-31	11232-11233	.	_

Text=Subsequently, based on the identified dominant GS and the individual-subject ’ s Fisher-transformed dynamic connectivity matrix (e.g., Xk), we estimated the corresponding dominant subject-specific state (SS) using a multiple-objective function optimization (see the following formula (1)).
86-1	11234-11246	Subsequently	_
86-2	11247-11248	,	_
86-3	11249-11254	based	_
86-4	11255-11257	on	_
86-5	11258-11261	the	_
86-6	11262-11272	identified	_
86-7	11273-11281	dominant	_
86-8	11282-11284	GS	_
86-9	11285-11288	and	_
86-10	11289-11292	the	_
86-11	11293-11311	individual-subject	_
86-12	11312-11313	’	_
86-13	11314-11315	s	_
86-14	11316-11334	Fisher-transformed	_
86-15	11335-11342	dynamic	_
86-16	11343-11355	connectivity	_
86-17	11356-11362	matrix	_
86-18	11363-11364	(	_
86-19	11365-11369	e.g.	_
86-20	11370-11371	,	_
86-21	11372-11374	Xk	_
86-22	11375-11376	)	_
86-23	11377-11378	,	_
86-24	11379-11381	we	_
86-25	11382-11391	estimated	_
86-26	11392-11395	the	_
86-27	11396-11409	corresponding	_
86-28	11410-11418	dominant	_
86-29	11419-11435	subject-specific	_
86-30	11436-11441	state	_
86-31	11442-11443	(	_
86-32	11444-11446	SS	_
86-33	11447-11448	)	_
86-34	11449-11454	using	_
86-35	11455-11456	a	_
86-36	11457-11475	multiple-objective	_
86-37	11476-11484	function	_
86-38	11485-11497	optimization	_
86-39	11498-11499	(	_
86-40	11500-11503	see	_
86-41	11504-11507	the	_
86-42	11508-11517	following	_
86-43	11518-11525	formula	_
86-44	11526-11527	(	_
86-45	11528-11529	1	_
86-46	11530-11531	)	_
86-47	11532-11533	)	_
86-48	11534-11535	.	_

Text=Fig.
87-1	11536-11539	Fig	_
87-2	11540-11541	.	_

Text=1C shows the schematic drawing of the step.
88-1	11542-11544	1C	_
88-2	11545-11550	shows	_
88-3	11551-11554	the	_
88-4	11555-11564	schematic	_
88-5	11565-11572	drawing	_
88-6	11573-11575	of	_
88-7	11576-11579	the	_
88-8	11580-11584	step	_
88-9	11585-11586	.	_

Text=In the procedure, the independence of the dominant SS as well as the correspondence between the dominant SS and the dominant GS were simultaneously optimized, resulting in accurate individual-level connectivity states that can be directly comparable across subjects.
89-1	11587-11589	In	_
89-2	11590-11593	the	_
89-3	11594-11603	procedure	_
89-4	11604-11605	,	_
89-5	11606-11609	the	_
89-6	11610-11622	independence	_
89-7	11623-11625	of	_
89-8	11626-11629	the	_
89-9	11630-11638	dominant	_
89-10	11639-11641	SS	_
89-11	11642-11644	as	_
89-12	11645-11649	well	_
89-13	11650-11652	as	_
89-14	11653-11656	the	_
89-15	11657-11671	correspondence	_
89-16	11672-11679	between	_
89-17	11680-11683	the	_
89-18	11684-11692	dominant	_
89-19	11693-11695	SS	_
89-20	11696-11699	and	_
89-21	11700-11703	the	_
89-22	11704-11712	dominant	_
89-23	11713-11715	GS	_
89-24	11716-11720	were	_
89-25	11721-11735	simultaneously	_
89-26	11736-11745	optimized	_
89-27	11746-11747	,	_
89-28	11748-11757	resulting	_
89-29	11758-11760	in	_
89-30	11761-11769	accurate	_
89-31	11770-11786	individual-level	_
89-32	11787-11799	connectivity	_
89-33	11800-11806	states	_
89-34	11807-11811	that	_
89-35	11812-11815	can	_
89-36	11816-11818	be	_
89-37	11819-11827	directly	_
89-38	11828-11838	comparable	_
89-39	11839-11845	across	_
89-40	11846-11854	subjects	_
89-41	11855-11856	.	_

Text=The optimization can directly yield Z-scored individual-level states with zero mean and unit variance.
90-1	11857-11860	The	_
90-2	11861-11873	optimization	_
90-3	11874-11877	can	_
90-4	11878-11886	directly	_
90-5	11887-11892	yield	_
90-6	11893-11901	Z-scored	_
90-7	11902-11918	individual-level	_
90-8	11919-11925	states	_
90-9	11926-11930	with	_
90-10	11931-11935	zero	_
90-11	11936-11940	mean	_
90-12	11941-11944	and	_
90-13	11945-11949	unit	_
90-14	11950-11958	variance	_
90-15	11959-11960	.	_

Text=In (1), represents the estimated dominant SS of the kth subject, where is the whitened Xk; is the unmixing column vector.
91-1	11961-11963	In	_
91-2	11964-11965	(	_
91-3	11966-11967	1	_
91-4	11968-11969	)	_
91-5	11970-11971	,	_
91-6	11972-11982	represents	_
91-7	11983-11986	the	_
91-8	11987-11996	estimated	_
91-9	11997-12005	dominant	_
91-10	12006-12008	SS	_
91-11	12009-12011	of	_
91-12	12012-12015	the	_
91-13	12016-12019	kth	_
91-14	12020-12027	subject	_
91-15	12028-12029	,	_
91-16	12030-12035	where	_
91-17	12036-12038	is	_
91-18	12039-12042	the	_
91-19	12043-12051	whitened	_
91-20	12052-12054	Xk	_
91-21	12055-12056	;	_
91-22	12057-12059	is	_
91-23	12060-12063	the	_
91-24	12064-12072	unmixing	_
91-25	12073-12079	column	_
91-26	12080-12086	vector	_
91-27	12087-12088	.	_

Text=The first function is for optimizing the independence measure of.
92-1	12089-12092	The	_
92-2	12093-12098	first	_
92-3	12099-12107	function	_
92-4	12108-12110	is	_
92-5	12111-12114	for	_
92-6	12115-12125	optimizing	_
92-7	12126-12129	the	_
92-8	12130-12142	independence	_
92-9	12143-12150	measure	_
92-10	12151-12153	of	_
92-11	12154-12155	.	_

Text=In our method,, the negentropy of, is used to reflect independence of.
93-1	12156-12158	In	_
93-2	12159-12162	our	_
93-3	12163-12169	method	_
93-4	12170-12171	,	_
93-5	12172-12173	,	_
93-6	12174-12177	the	_
93-7	12178-12188	negentropy	_
93-8	12189-12191	of	_
93-9	12192-12193	,	_
93-10	12194-12196	is	_
93-11	12197-12201	used	_
93-12	12202-12204	to	_
93-13	12205-12212	reflect	_
93-14	12213-12225	independence	_
93-15	12226-12228	of	_
93-16	12229-12230	.	_

Text=Here, ν is a is a Gaussian variable with zero mean and unit variance; G (·) is a nonquadratic function.
94-1	12231-12235	Here	_
94-2	12236-12237	,	_
94-3	12238-12239	ν	_
94-4	12240-12242	is	_
94-5	12243-12244	a	_
94-6	12245-12247	is	_
94-7	12248-12249	a	_
94-8	12250-12258	Gaussian	_
94-9	12259-12267	variable	_
94-10	12268-12272	with	_
94-11	12273-12277	zero	_
94-12	12278-12282	mean	_
94-13	12283-12286	and	_
94-14	12287-12291	unit	_
94-15	12292-12300	variance	_
94-16	12301-12302	;	_
94-17	12303-12304	G	_
94-18	12305-12306	(	_
94-19	12307-12308	·	_
94-20	12309-12310	)	_
94-21	12311-12313	is	_
94-22	12314-12315	a	_
94-23	12316-12328	nonquadratic	_
94-24	12329-12337	function	_
94-25	12338-12339	.	_

Text=The second function is used to measure the similarity (i.e., correspondence) between Sl.
95-1	12340-12343	The	_
95-2	12344-12350	second	_
95-3	12351-12359	function	_
95-4	12360-12362	is	_
95-5	12363-12367	used	_
95-6	12368-12370	to	_
95-7	12371-12378	measure	_
95-8	12379-12382	the	_
95-9	12383-12393	similarity	_
95-10	12394-12395	(	_
95-11	12396-12400	i.e.	_
95-12	12401-12402	,	_
95-13	12403-12417	correspondence	_
95-14	12418-12419	)	_
95-15	12420-12427	between	_
95-16	12428-12430	Sl	_
95-17	12431-12432	.	_

Text=and.
96-1	12433-12436	and	_
96-2	12437-12438	.	_

Text=E [] denotes the expectation of variable.
97-1	12439-12440	E	_
97-2	12441-12442	[	_
97-3	12443-12444	]	_
97-4	12445-12452	denotes	_
97-5	12453-12456	the	_
97-6	12457-12468	expectation	_
97-7	12469-12471	of	_
97-8	12472-12480	variable	_
97-9	12481-12482	.	_

Text=By derivation, equals to Pearson correlation between Sl and.
98-1	12483-12485	By	_
98-2	12486-12496	derivation	_
98-3	12497-12498	,	_
98-4	12499-12505	equals	_
98-5	12506-12508	to	_
98-6	12509-12516	Pearson	_
98-7	12517-12528	correlation	_
98-8	12529-12536	between	_
98-9	12537-12539	Sl	_
98-10	12540-12543	and	_
98-11	12544-12545	.	_

Text=To solve the multiple-objective function optimization, a linear weighted sum method was applied to combine the two objectives.
99-1	12546-12548	To	_
99-2	12549-12554	solve	_
99-3	12555-12558	the	_
99-4	12559-12577	multiple-objective	_
99-5	12578-12586	function	_
99-6	12587-12599	optimization	_
99-7	12600-12601	,	_
99-8	12602-12603	a	_
99-9	12604-12610	linear	_
99-10	12611-12619	weighted	_
99-11	12620-12623	sum	_
99-12	12624-12630	method	_
99-13	12631-12634	was	_
99-14	12635-12642	applied	_
99-15	12643-12645	to	_
99-16	12646-12653	combine	_
99-17	12654-12657	the	_
99-18	12658-12661	two	_
99-19	12662-12672	objectives	_
99-20	12673-12674	.	_

Text=After the optimization, the dominant subject-specific states were obtained.
100-1	12675-12680	After	_
100-2	12681-12684	the	_
100-3	12685-12697	optimization	_
100-4	12698-12699	,	_
100-5	12700-12703	the	_
100-6	12704-12712	dominant	_
100-7	12713-12729	subject-specific	_
100-8	12730-12736	states	_
100-9	12737-12741	were	_
100-10	12742-12750	obtained	_
100-11	12751-12752	.	_

Text=Derived from the above mentioned analyses, each of the group-level and individual-subject connectivity states is denoted by a Z-scored component (size: 1 × 6670).
101-1	12753-12760	Derived	_
101-2	12761-12765	from	_
101-3	12766-12769	the	_
101-4	12770-12775	above	_
101-5	12776-12785	mentioned	_
101-6	12786-12794	analyses	_
101-7	12795-12796	,	_
101-8	12797-12801	each	_
101-9	12802-12804	of	_
101-10	12805-12808	the	_
101-11	12809-12820	group-level	_
101-12	12821-12824	and	_
101-13	12825-12843	individual-subject	_
101-14	12844-12856	connectivity	_
101-15	12857-12863	states	_
101-16	12864-12866	is	_
101-17	12867-12874	denoted	_
101-18	12875-12877	by	_
101-19	12878-12879	a	_
101-20	12880-12888	Z-scored	_
101-21	12889-12898	component	_
101-22	12899-12900	(	_
101-23	12901-12905	size	_
101-24	12906-12907	:	_
101-25	12908-12909	1	_
101-26	12910-12911	×	_
101-27	12912-12916	6670	_
101-28	12917-12918	)	_
101-29	12919-12920	.	_

Text=We then converted each component to a 116 × 116 symmetric matrix, so each element of the symmetric matrix reflects the relationship between one pair of ROIs.
102-1	12921-12923	We	_
102-2	12924-12928	then	_
102-3	12929-12938	converted	_
102-4	12939-12943	each	_
102-5	12944-12953	component	_
102-6	12954-12956	to	_
102-7	12957-12958	a	_
102-8	12959-12962	116	_
102-9	12963-12964	×	_
102-10	12965-12968	116	_
102-11	12969-12978	symmetric	_
102-12	12979-12985	matrix	_
102-13	12986-12987	,	_
102-14	12988-12990	so	_
102-15	12991-12995	each	_
102-16	12996-13003	element	_
102-17	13004-13006	of	_
102-18	13007-13010	the	_
102-19	13011-13020	symmetric	_
102-20	13021-13027	matrix	_
102-21	13028-13036	reflects	_
102-22	13037-13040	the	_
102-23	13041-13053	relationship	_
102-24	13054-13061	between	_
102-25	13062-13065	one	_
102-26	13066-13070	pair	_
102-27	13071-13073	of	_
102-28	13074-13078	ROIs	_
102-29	13079-13080	.	_

Text=It is worth pointing out that the positive and negative values in the symmetric matrix of each GS should be interpreted along with the state ’ s loadings (i.e., SFs) due to the ambiguity of the signs of components (i.e., states).
103-1	13081-13083	It	_
103-2	13084-13086	is	_
103-3	13087-13092	worth	_
103-4	13093-13101	pointing	_
103-5	13102-13105	out	_
103-6	13106-13110	that	_
103-7	13111-13114	the	_
103-8	13115-13123	positive	_
103-9	13124-13127	and	_
103-10	13128-13136	negative	_
103-11	13137-13143	values	_
103-12	13144-13146	in	_
103-13	13147-13150	the	_
103-14	13151-13160	symmetric	_
103-15	13161-13167	matrix	_
103-16	13168-13170	of	_
103-17	13171-13175	each	_
103-18	13176-13178	GS	_
103-19	13179-13185	should	_
103-20	13186-13188	be	_
103-21	13189-13200	interpreted	_
103-22	13201-13206	along	_
103-23	13207-13211	with	_
103-24	13212-13215	the	_
103-25	13216-13221	state	_
103-26	13222-13223	’	_
103-27	13224-13225	s	_
103-28	13226-13234	loadings	_
103-29	13235-13236	(	_
103-30	13237-13241	i.e.	_
103-31	13242-13243	,	_
103-32	13244-13247	SFs	_
103-33	13248-13249	)	_
103-34	13250-13253	due	_
103-35	13254-13256	to	_
103-36	13257-13260	the	_
103-37	13261-13270	ambiguity	_
103-38	13271-13273	of	_
103-39	13274-13277	the	_
103-40	13278-13283	signs	_
103-41	13284-13286	of	_
103-42	13287-13297	components	_
103-43	13298-13299	(	_
103-44	13300-13304	i.e.	_
103-45	13305-13306	,	_
103-46	13307-13313	states	_
103-47	13314-13315	)	_
103-48	13316-13317	.	_

Text=If one state ’ s SF values are positive, it means that its contribution to time-varying connectivity is positive.
104-1	13318-13320	If	_
104-2	13321-13324	one	_
104-3	13325-13330	state	_
104-4	13331-13332	’	_
104-5	13333-13334	s	_
104-6	13335-13337	SF	_
104-7	13338-13344	values	_
104-8	13345-13348	are	_
104-9	13349-13357	positive	_
104-10	13358-13359	,	_
104-11	13360-13362	it	_
104-12	13363-13368	means	_
104-13	13369-13373	that	_
104-14	13374-13377	its	_
104-15	13378-13390	contribution	_
104-16	13391-13393	to	_
104-17	13394-13406	time-varying	_
104-18	13407-13419	connectivity	_
104-19	13420-13422	is	_
104-20	13423-13431	positive	_
104-21	13432-13433	.	_

Text=So, the positive/negative values in the state (i.e., the positive/negative values in the symmetric matrix) reflect the positive/negative connectivity strengths between ROIs.
105-1	13434-13436	So	_
105-2	13437-13438	,	_
105-3	13439-13442	the	_
105-4	13443-13460	positive/negative	_
105-5	13461-13467	values	_
105-6	13468-13470	in	_
105-7	13471-13474	the	_
105-8	13475-13480	state	_
105-9	13481-13482	(	_
105-10	13483-13487	i.e.	_
105-11	13488-13489	,	_
105-12	13490-13493	the	_
105-13	13494-13511	positive/negative	_
105-14	13512-13518	values	_
105-15	13519-13521	in	_
105-16	13522-13525	the	_
105-17	13526-13535	symmetric	_
105-18	13536-13542	matrix	_
105-19	13543-13544	)	_
105-20	13545-13552	reflect	_
105-21	13553-13556	the	_
105-22	13557-13574	positive/negative	_
105-23	13575-13587	connectivity	_
105-24	13588-13597	strengths	_
105-25	13598-13605	between	_
105-26	13606-13610	ROIs	_
105-27	13611-13612	.	_

Text=If one state ’ s SF values have both positive and negative values, the values in the symmetric matrix don ’ t directly correspond to the connectivity strengths.
106-1	13613-13615	If	_
106-2	13616-13619	one	_
106-3	13620-13625	state	_
106-4	13626-13627	’	_
106-5	13628-13629	s	_
106-6	13630-13632	SF	_
106-7	13633-13639	values	_
106-8	13640-13644	have	_
106-9	13645-13649	both	_
106-10	13650-13658	positive	_
106-11	13659-13662	and	_
106-12	13663-13671	negative	_
106-13	13672-13678	values	_
106-14	13679-13680	,	_
106-15	13681-13684	the	_
106-16	13685-13691	values	_
106-17	13692-13694	in	_
106-18	13695-13698	the	_
106-19	13699-13708	symmetric	_
106-20	13709-13715	matrix	_
106-21	13716-13719	don	_
106-22	13720-13721	’	_
106-23	13722-13723	t	_
106-24	13724-13732	directly	_
106-25	13733-13743	correspond	_
106-26	13744-13746	to	_
106-27	13747-13750	the	_
106-28	13751-13763	connectivity	_
106-29	13764-13773	strengths	_
106-30	13774-13775	.	_

Text=In that case, the positive (or negative) value in SF means that the state (or anti-state) exists in the corresponding window ’ s functional connectivity.
107-1	13776-13778	In	_
107-2	13779-13783	that	_
107-3	13784-13788	case	_
107-4	13789-13790	,	_
107-5	13791-13794	the	_
107-6	13795-13803	positive	_
107-7	13804-13805	(	_
107-8	13806-13808	or	_
107-9	13809-13817	negative	_
107-10	13818-13819	)	_
107-11	13820-13825	value	_
107-12	13826-13828	in	_
107-13	13829-13831	SF	_
107-14	13832-13837	means	_
107-15	13838-13842	that	_
107-16	13843-13846	the	_
107-17	13847-13852	state	_
107-18	13853-13854	(	_
107-19	13855-13857	or	_
107-20	13858-13868	anti-state	_
107-21	13869-13870	)	_
107-22	13871-13877	exists	_
107-23	13878-13880	in	_
107-24	13881-13884	the	_
107-25	13885-13898	corresponding	_
107-26	13899-13905	window	_
107-27	13906-13907	’	_
107-28	13908-13909	s	_
107-29	13910-13920	functional	_
107-30	13921-13933	connectivity	_
107-31	13934-13935	.	_

Text=2.2.3.
108-1	13936-13941	2.2.3	_
108-2	13942-13943	.	_

Text=Investigating group differences in the functional connectivity states In the section, we focus on investigating group differences in the connectivity states, aiming to explore whether CHR individuals tend to be intermediate between HC subjects and ESZ patients and what measures could be employed as potential biomarkers for CHR and ESZ.
109-1	13944-13957	Investigating	_
109-2	13958-13963	group	_
109-3	13964-13975	differences	_
109-4	13976-13978	in	_
109-5	13979-13982	the	_
109-6	13983-13993	functional	_
109-7	13994-14006	connectivity	_
109-8	14007-14013	states	_
109-9	14014-14016	In	_
109-10	14017-14020	the	_
109-11	14021-14028	section	_
109-12	14029-14030	,	_
109-13	14031-14033	we	_
109-14	14034-14039	focus	_
109-15	14040-14042	on	_
109-16	14043-14056	investigating	_
109-17	14057-14062	group	_
109-18	14063-14074	differences	_
109-19	14075-14077	in	_
109-20	14078-14081	the	_
109-21	14082-14094	connectivity	_
109-22	14095-14101	states	_
109-23	14102-14103	,	_
109-24	14104-14110	aiming	_
109-25	14111-14113	to	_
109-26	14114-14121	explore	_
109-27	14122-14129	whether	_
109-28	14130-14133	CHR	_
109-29	14134-14145	individuals	_
109-30	14146-14150	tend	_
109-31	14151-14153	to	_
109-32	14154-14156	be	_
109-33	14157-14169	intermediate	_
109-34	14170-14177	between	_
109-35	14178-14180	HC	_
109-36	14181-14189	subjects	_
109-37	14190-14193	and	_
109-38	14194-14197	ESZ	_
109-39	14198-14206	patients	_
109-40	14207-14210	and	_
109-41	14211-14215	what	_
109-42	14216-14224	measures	_
109-43	14225-14230	could	_
109-44	14231-14233	be	_
109-45	14234-14242	employed	_
109-46	14243-14245	as	_
109-47	14246-14255	potential	_
109-48	14256-14266	biomarkers	_
109-49	14267-14270	for	_
109-50	14271-14274	CHR	_
109-51	14275-14278	and	_
109-52	14279-14282	ESZ	_
109-53	14283-14284	.	_

Text=Similar to our previous work, we matched results among the three groups in order to compare the corresponding states.
110-1	14285-14292	Similar	_
110-2	14293-14295	to	_
110-3	14296-14299	our	_
110-4	14300-14308	previous	_
110-5	14309-14313	work	_
110-6	14314-14315	,	_
110-7	14316-14318	we	_
110-8	14319-14326	matched	_
110-9	14327-14334	results	_
110-10	14335-14340	among	_
110-11	14341-14344	the	_
110-12	14345-14350	three	_
110-13	14351-14357	groups	_
110-14	14358-14360	in	_
110-15	14361-14366	order	_
110-16	14367-14369	to	_
110-17	14370-14377	compare	_
110-18	14378-14381	the	_
110-19	14382-14395	corresponding	_
110-20	14396-14402	states	_
110-21	14403-14404	.	_

Text=The detailed matching method is described in the supplementary materials.
111-1	14405-14408	The	_
111-2	14409-14417	detailed	_
111-3	14418-14426	matching	_
111-4	14427-14433	method	_
111-5	14434-14436	is	_
111-6	14437-14446	described	_
111-7	14447-14449	in	_
111-8	14450-14453	the	_
111-9	14454-14467	supplementary	_
111-10	14468-14477	materials	_
111-11	14478-14479	.	_

Text=After that, we visualized each of GSs using the BrainNet Viewer toolbox to reflect the related connectivity pattern among ROIs.
112-1	14480-14485	After	_
112-2	14486-14490	that	_
112-3	14491-14492	,	_
112-4	14493-14495	we	_
112-5	14496-14506	visualized	_
112-6	14507-14511	each	_
112-7	14512-14514	of	_
112-8	14515-14518	GSs	_
112-9	14519-14524	using	_
112-10	14525-14528	the	_
112-11	14529-14537	BrainNet	_
112-12	14538-14544	Viewer	_
112-13	14545-14552	toolbox	_
112-14	14553-14555	to	_
112-15	14556-14563	reflect	_
112-16	14564-14567	the	_
112-17	14568-14575	related	_
112-18	14576-14588	connectivity	_
112-19	14589-14596	pattern	_
112-20	14597-14602	among	_
112-21	14603-14607	ROIs	_
112-22	14608-14609	.	_

Text=Next, to assess the relationship (similarity or disparity) of the matched GSs across the three groups, we computed Pearson correlation coefficient between any pair of GSs, resulting in a correlation matrix (size: 3 × 3).
113-1	14610-14614	Next	_
113-2	14615-14616	,	_
113-3	14617-14619	to	_
113-4	14620-14626	assess	_
113-5	14627-14630	the	_
113-6	14631-14643	relationship	_
113-7	14644-14645	(	_
113-8	14646-14656	similarity	_
113-9	14657-14659	or	_
113-10	14660-14669	disparity	_
113-11	14670-14671	)	_
113-12	14672-14674	of	_
113-13	14675-14678	the	_
113-14	14679-14686	matched	_
113-15	14687-14690	GSs	_
113-16	14691-14697	across	_
113-17	14698-14701	the	_
113-18	14702-14707	three	_
113-19	14708-14714	groups	_
113-20	14715-14716	,	_
113-21	14717-14719	we	_
113-22	14720-14728	computed	_
113-23	14729-14736	Pearson	_
113-24	14737-14748	correlation	_
113-25	14749-14760	coefficient	_
113-26	14761-14768	between	_
113-27	14769-14772	any	_
113-28	14773-14777	pair	_
113-29	14778-14780	of	_
113-30	14781-14784	GSs	_
113-31	14785-14786	,	_
113-32	14787-14796	resulting	_
113-33	14797-14799	in	_
113-34	14800-14801	a	_
113-35	14802-14813	correlation	_
113-36	14814-14820	matrix	_
113-37	14821-14822	(	_
113-38	14823-14827	size	_
113-39	14828-14829	:	_
113-40	14830-14831	3	_
113-41	14832-14833	×	_
113-42	14834-14835	3	_
113-43	14836-14837	)	_
113-44	14838-14839	.	_

Text=The upper triangular elements of the correlation matrix include rHC–CHR, rHC–ESZ, and rCHR–ESZ.
114-1	14840-14843	The	_
114-2	14844-14849	upper	_
114-3	14850-14860	triangular	_
114-4	14861-14869	elements	_
114-5	14870-14872	of	_
114-6	14873-14876	the	_
114-7	14877-14888	correlation	_
114-8	14889-14895	matrix	_
114-9	14896-14903	include	_
114-10	14904-14911	rHC–CHR	_
114-11	14912-14913	,	_
114-12	14914-14921	rHC–ESZ	_
114-13	14922-14923	,	_
114-14	14924-14927	and	_
114-15	14928-14936	rCHR–ESZ	_
114-16	14937-14938	.	_

Text=Here, rHC–CHR denotes the correlation between the GS of HC group and the GS of CHR group.
115-1	14939-14943	Here	_
115-2	14944-14945	,	_
115-3	14946-14953	rHC–CHR	_
115-4	14954-14961	denotes	_
115-5	14962-14965	the	_
115-6	14966-14977	correlation	_
115-7	14978-14985	between	_
115-8	14986-14989	the	_
115-9	14990-14992	GS	_
115-10	14993-14995	of	_
115-11	14996-14998	HC	_
115-12	14999-15004	group	_
115-13	15005-15008	and	_
115-14	15009-15012	the	_
115-15	15013-15015	GS	_
115-16	15016-15018	of	_
115-17	15019-15022	CHR	_
115-18	15023-15028	group	_
115-19	15029-15030	.	_

Text=Then, we took the mean of the absolute correlations in the similarity matrix as the overall similarity measure of the matched GSs.
116-1	15031-15035	Then	_
116-2	15036-15037	,	_
116-3	15038-15040	we	_
116-4	15041-15045	took	_
116-5	15046-15049	the	_
116-6	15050-15054	mean	_
116-7	15055-15057	of	_
116-8	15058-15061	the	_
116-9	15062-15070	absolute	_
116-10	15071-15083	correlations	_
116-11	15084-15086	in	_
116-12	15087-15090	the	_
116-13	15091-15101	similarity	_
116-14	15102-15108	matrix	_
116-15	15109-15111	as	_
116-16	15112-15115	the	_
116-17	15116-15123	overall	_
116-18	15124-15134	similarity	_
116-19	15135-15142	measure	_
116-20	15143-15145	of	_
116-21	15146-15149	the	_
116-22	15150-15157	matched	_
116-23	15158-15161	GSs	_
116-24	15162-15163	.	_

Text=Furthermore, we examined if the inter-group relationships of GSs are statistically significant using multiple permutation runs.
117-1	15164-15175	Furthermore	_
117-2	15176-15177	,	_
117-3	15178-15180	we	_
117-4	15181-15189	examined	_
117-5	15190-15192	if	_
117-6	15193-15196	the	_
117-7	15197-15208	inter-group	_
117-8	15209-15222	relationships	_
117-9	15223-15225	of	_
117-10	15226-15229	GSs	_
117-11	15230-15233	are	_
117-12	15234-15247	statistically	_
117-13	15248-15259	significant	_
117-14	15260-15265	using	_
117-15	15266-15274	multiple	_
117-16	15275-15286	permutation	_
117-17	15287-15291	runs	_
117-18	15292-15293	.	_

Text=For each group, we generated 100 permutations, each of which randomly included 85% samples of the original subjects.
118-1	15294-15297	For	_
118-2	15298-15302	each	_
118-3	15303-15308	group	_
118-4	15309-15310	,	_
118-5	15311-15313	we	_
118-6	15314-15323	generated	_
118-7	15324-15327	100	_
118-8	15328-15340	permutations	_
118-9	15341-15342	,	_
118-10	15343-15347	each	_
118-11	15348-15350	of	_
118-12	15351-15356	which	_
118-13	15357-15365	randomly	_
118-14	15366-15374	included	_
118-15	15375-15377	85	_
118-16	15378-15379	%	_
118-17	15380-15387	samples	_
118-18	15388-15390	of	_
118-19	15391-15394	the	_
118-20	15395-15403	original	_
118-21	15404-15412	subjects	_
118-22	15413-15414	.	_

Text=In each permutation run, the group-level ICA (shown in Fig.
119-1	15415-15417	In	_
119-2	15418-15422	each	_
119-3	15423-15434	permutation	_
119-4	15435-15438	run	_
119-5	15439-15440	,	_
119-6	15441-15444	the	_
119-7	15445-15456	group-level	_
119-8	15457-15460	ICA	_
119-9	15461-15462	(	_
119-10	15463-15468	shown	_
119-11	15469-15471	in	_
119-12	15472-15475	Fig	_
119-13	15476-15477	.	_

Text=1B) was applied to analyze the selected subjects ’ dynamic connectivity, resulting in new GSs of the group.
120-1	15478-15480	1B	_
120-2	15481-15482	)	_
120-3	15483-15486	was	_
120-4	15487-15494	applied	_
120-5	15495-15497	to	_
120-6	15498-15505	analyze	_
120-7	15506-15509	the	_
120-8	15510-15518	selected	_
120-9	15519-15527	subjects	_
120-10	15528-15529	’	_
120-11	15530-15537	dynamic	_
120-12	15538-15550	connectivity	_
120-13	15551-15552	,	_
120-14	15553-15562	resulting	_
120-15	15563-15565	in	_
120-16	15566-15569	new	_
120-17	15570-15573	GSs	_
120-18	15574-15576	of	_
120-19	15577-15580	the	_
120-20	15581-15586	group	_
120-21	15587-15588	.	_

Text=For each group, we then matched the new GSs from each permutation run with the GSs obtained from the original samples using a greedy search rule.
121-1	15589-15592	For	_
121-2	15593-15597	each	_
121-3	15598-15603	group	_
121-4	15604-15605	,	_
121-5	15606-15608	we	_
121-6	15609-15613	then	_
121-7	15614-15621	matched	_
121-8	15622-15625	the	_
121-9	15626-15629	new	_
121-10	15630-15633	GSs	_
121-11	15634-15638	from	_
121-12	15639-15643	each	_
121-13	15644-15655	permutation	_
121-14	15656-15659	run	_
121-15	15660-15664	with	_
121-16	15665-15668	the	_
121-17	15669-15672	GSs	_
121-18	15673-15681	obtained	_
121-19	15682-15686	from	_
121-20	15687-15690	the	_
121-21	15691-15699	original	_
121-22	15700-15707	samples	_
121-23	15708-15713	using	_
121-24	15714-15715	a	_
121-25	15716-15722	greedy	_
121-26	15723-15729	search	_
121-27	15730-15734	rule	_
121-28	15735-15736	.	_

Text=So, the new GSs from each permutation run were re-sorted to provide correspondence across the three groups.
122-1	15737-15739	So	_
122-2	15740-15741	,	_
122-3	15742-15745	the	_
122-4	15746-15749	new	_
122-5	15750-15753	GSs	_
122-6	15754-15758	from	_
122-7	15759-15763	each	_
122-8	15764-15775	permutation	_
122-9	15776-15779	run	_
122-10	15780-15784	were	_
122-11	15785-15794	re-sorted	_
122-12	15795-15797	to	_
122-13	15798-15805	provide	_
122-14	15806-15820	correspondence	_
122-15	15821-15827	across	_
122-16	15828-15831	the	_
122-17	15832-15837	three	_
122-18	15838-15844	groups	_
122-19	15845-15846	.	_

Text=Regarding each of 100 runs, a 3 × 3 correlation matrix associated with one state can be computed, representing the inter-group relationship of GSs in the run.
123-1	15847-15856	Regarding	_
123-2	15857-15861	each	_
123-3	15862-15864	of	_
123-4	15865-15868	100	_
123-5	15869-15873	runs	_
123-6	15874-15875	,	_
123-7	15876-15877	a	_
123-8	15878-15879	3	_
123-9	15880-15881	×	_
123-10	15882-15883	3	_
123-11	15884-15895	correlation	_
123-12	15896-15902	matrix	_
123-13	15903-15913	associated	_
123-14	15914-15918	with	_
123-15	15919-15922	one	_
123-16	15923-15928	state	_
123-17	15929-15932	can	_
123-18	15933-15935	be	_
123-19	15936-15944	computed	_
123-20	15945-15946	,	_
123-21	15947-15959	representing	_
123-22	15960-15963	the	_
123-23	15964-15975	inter-group	_
123-24	15976-15988	relationship	_
123-25	15989-15991	of	_
123-26	15992-15995	GSs	_
123-27	15996-15998	in	_
123-28	15999-16002	the	_
123-29	16003-16006	run	_
123-30	16007-16008	.	_

Text=Finally, for each state, we investigated if rHC–CHR, rHC–ESZ, and rCHR–ESZ had significant differences by performing two-tailed two-sample t-tests between rHC–CHR and rHC–ESZ, between rCHR–ESZ.
124-1	16009-16016	Finally	_
124-2	16017-16018	,	_
124-3	16019-16022	for	_
124-4	16023-16027	each	_
124-5	16028-16033	state	_
124-6	16034-16035	,	_
124-7	16036-16038	we	_
124-8	16039-16051	investigated	_
124-9	16052-16054	if	_
124-10	16055-16062	rHC–CHR	_
124-11	16063-16064	,	_
124-12	16065-16072	rHC–ESZ	_
124-13	16073-16074	,	_
124-14	16075-16078	and	_
124-15	16079-16087	rCHR–ESZ	_
124-16	16088-16091	had	_
124-17	16092-16103	significant	_
124-18	16104-16115	differences	_
124-19	16116-16118	by	_
124-20	16119-16129	performing	_
124-21	16130-16140	two-tailed	_
124-22	16141-16151	two-sample	_
124-23	16152-16159	t-tests	_
124-24	16160-16167	between	_
124-25	16168-16175	rHC–CHR	_
124-26	16176-16179	and	_
124-27	16180-16187	rHC–ESZ	_
124-28	16188-16189	,	_
124-29	16190-16197	between	_
124-30	16198-16206	rCHR–ESZ	_
124-31	16207-16208	.	_

Text=and rHC–CHR, as well as between rCHR–ESZ and rHR–ESZ based on the values from 100 permutation runs.
125-1	16209-16212	and	_
125-2	16213-16220	rHC–CHR	_
125-3	16221-16222	,	_
125-4	16223-16225	as	_
125-5	16226-16230	well	_
125-6	16231-16233	as	_
125-7	16234-16241	between	_
125-8	16242-16250	rCHR–ESZ	_
125-9	16251-16254	and	_
125-10	16255-16262	rHR–ESZ	_
125-11	16263-16268	based	_
125-12	16269-16271	on	_
125-13	16272-16275	the	_
125-14	16276-16282	values	_
125-15	16283-16287	from	_
125-16	16288-16291	100	_
125-17	16292-16303	permutation	_
125-18	16304-16308	runs	_
125-19	16309-16310	.	_

Text=Significant level was set to p <0.01 with Bonferroni correction (i.e., p <0.01/15).
126-1	16311-16322	Significant	_
126-2	16323-16328	level	_
126-3	16329-16332	was	_
126-4	16333-16336	set	_
126-5	16337-16339	to	_
126-6	16340-16341	p	_
126-7	16342-16343	<	_
126-8	16344-16348	0.01	_
126-9	16349-16353	with	_
126-10	16354-16364	Bonferroni	_
126-11	16365-16375	correction	_
126-12	16376-16377	(	_
126-13	16378-16382	i.e.	_
126-14	16383-16384	,	_
126-15	16385-16386	p	_
126-16	16387-16388	<	_
126-17	16389-16396	0.01/15	_
126-18	16397-16398	)	_
126-19	16399-16400	.	_

Text=Due to the importance of the dominant state (with the most contribution to the dynamic connectivity), we investigated its group differences in detail.
127-1	16401-16404	Due	_
127-2	16405-16407	to	_
127-3	16408-16411	the	_
127-4	16412-16422	importance	_
127-5	16423-16425	of	_
127-6	16426-16429	the	_
127-7	16430-16438	dominant	_
127-8	16439-16444	state	_
127-9	16445-16446	(	_
127-10	16447-16451	with	_
127-11	16452-16455	the	_
127-12	16456-16460	most	_
127-13	16461-16473	contribution	_
127-14	16474-16476	to	_
127-15	16477-16480	the	_
127-16	16481-16488	dynamic	_
127-17	16489-16501	connectivity	_
127-18	16502-16503	)	_
127-19	16504-16505	,	_
127-20	16506-16508	we	_
127-21	16509-16521	investigated	_
127-22	16522-16525	its	_
127-23	16526-16531	group	_
127-24	16532-16543	differences	_
127-25	16544-16546	in	_
127-26	16547-16553	detail	_
127-27	16554-16555	.	_

Text=First, we averaged the dominant SSs across subjects for each group to see if the connectivity patterns are disparate (or consistent) across groups.
128-1	16556-16561	First	_
128-2	16562-16563	,	_
128-3	16564-16566	we	_
128-4	16567-16575	averaged	_
128-5	16576-16579	the	_
128-6	16580-16588	dominant	_
128-7	16589-16592	SSs	_
128-8	16593-16599	across	_
128-9	16600-16608	subjects	_
128-10	16609-16612	for	_
128-11	16613-16617	each	_
128-12	16618-16623	group	_
128-13	16624-16626	to	_
128-14	16627-16630	see	_
128-15	16631-16633	if	_
128-16	16634-16637	the	_
128-17	16638-16650	connectivity	_
128-18	16651-16659	patterns	_
128-19	16660-16663	are	_
128-20	16664-16673	disparate	_
128-21	16674-16675	(	_
128-22	16676-16678	or	_
128-23	16679-16689	consistent	_
128-24	16690-16691	)	_
128-25	16692-16698	across	_
128-26	16699-16705	groups	_
128-27	16706-16707	.	_

Text=Then, analysis of covariance (ANCOVA) with age and gender as covariates was performed on each connection ’ s strengths in the dominant SSs to investigate the group difference of three groups.
129-1	16708-16712	Then	_
129-2	16713-16714	,	_
129-3	16715-16723	analysis	_
129-4	16724-16726	of	_
129-5	16727-16737	covariance	_
129-6	16738-16739	(	_
129-7	16740-16746	ANCOVA	_
129-8	16747-16748	)	_
129-9	16749-16753	with	_
129-10	16754-16757	age	_
129-11	16758-16761	and	_
129-12	16762-16768	gender	_
129-13	16769-16771	as	_
129-14	16772-16782	covariates	_
129-15	16783-16786	was	_
129-16	16787-16796	performed	_
129-17	16797-16799	on	_
129-18	16800-16804	each	_
129-19	16805-16815	connection	_
129-20	16816-16817	’	_
129-21	16818-16819	s	_
129-22	16820-16829	strengths	_
129-23	16830-16832	in	_
129-24	16833-16836	the	_
129-25	16837-16845	dominant	_
129-26	16846-16849	SSs	_
129-27	16850-16852	to	_
129-28	16853-16864	investigate	_
129-29	16865-16868	the	_
129-30	16869-16874	group	_
129-31	16875-16885	difference	_
129-32	16886-16888	of	_
129-33	16889-16894	three	_
129-34	16895-16901	groups	_
129-35	16902-16903	.	_

Text=Afterwards, based on each connectivity showing group differences identified by ANCOVA (p <0.05 with Bonferroni correction), we applied a two-tailed two-sample t-test (p <0.05 with Bonferroni correction) to assess differences in connectivity strength between any pair of groups.
130-1	16904-16914	Afterwards	_
130-2	16915-16916	,	_
130-3	16917-16922	based	_
130-4	16923-16925	on	_
130-5	16926-16930	each	_
130-6	16931-16943	connectivity	_
130-7	16944-16951	showing	_
130-8	16952-16957	group	_
130-9	16958-16969	differences	_
130-10	16970-16980	identified	_
130-11	16981-16983	by	_
130-12	16984-16990	ANCOVA	_
130-13	16991-16992	(	_
130-14	16993-16994	p	_
130-15	16995-16996	<	_
130-16	16997-17001	0.05	_
130-17	17002-17006	with	_
130-18	17007-17017	Bonferroni	_
130-19	17018-17028	correction	_
130-20	17029-17030	)	_
130-21	17031-17032	,	_
130-22	17033-17035	we	_
130-23	17036-17043	applied	_
130-24	17044-17045	a	_
130-25	17046-17056	two-tailed	_
130-26	17057-17067	two-sample	_
130-27	17068-17074	t-test	_
130-28	17075-17076	(	_
130-29	17077-17078	p	_
130-30	17079-17080	<	_
130-31	17081-17085	0.05	_
130-32	17086-17090	with	_
130-33	17091-17101	Bonferroni	_
130-34	17102-17112	correction	_
130-35	17113-17114	)	_
130-36	17115-17117	to	_
130-37	17118-17124	assess	_
130-38	17125-17136	differences	_
130-39	17137-17139	in	_
130-40	17140-17152	connectivity	_
130-41	17153-17161	strength	_
130-42	17162-17169	between	_
130-43	17170-17173	any	_
130-44	17174-17178	pair	_
130-45	17179-17181	of	_
130-46	17182-17188	groups	_
130-47	17189-17190	.	_

Text=Finally, for each connection with significant group difference, Pearson correlation coefficients between the connectivity strengths and symptom severity scores (shown in Table 1) were computed for the CHR and ESZ groups, respectively, in order to explore the associations between potential biomarkers and clinical symptoms.
131-1	17191-17198	Finally	_
131-2	17199-17200	,	_
131-3	17201-17204	for	_
131-4	17205-17209	each	_
131-5	17210-17220	connection	_
131-6	17221-17225	with	_
131-7	17226-17237	significant	_
131-8	17238-17243	group	_
131-9	17244-17254	difference	_
131-10	17255-17256	,	_
131-11	17257-17264	Pearson	_
131-12	17265-17276	correlation	_
131-13	17277-17289	coefficients	_
131-14	17290-17297	between	_
131-15	17298-17301	the	_
131-16	17302-17314	connectivity	_
131-17	17315-17324	strengths	_
131-18	17325-17328	and	_
131-19	17329-17336	symptom	_
131-20	17337-17345	severity	_
131-21	17346-17352	scores	_
131-22	17353-17354	(	_
131-23	17355-17360	shown	_
131-24	17361-17363	in	_
131-25	17364-17369	Table	_
131-26	17370-17371	1	_
131-27	17372-17373	)	_
131-28	17374-17378	were	_
131-29	17379-17387	computed	_
131-30	17388-17391	for	_
131-31	17392-17395	the	_
131-32	17396-17399	CHR	_
131-33	17400-17403	and	_
131-34	17404-17407	ESZ	_
131-35	17408-17414	groups	_
131-36	17415-17416	,	_
131-37	17417-17429	respectively	_
131-38	17430-17431	,	_
131-39	17432-17434	in	_
131-40	17435-17440	order	_
131-41	17441-17443	to	_
131-42	17444-17451	explore	_
131-43	17452-17455	the	_
131-44	17456-17468	associations	_
131-45	17469-17476	between	_
131-46	17477-17486	potential	_
131-47	17487-17497	biomarkers	_
131-48	17498-17501	and	_
131-49	17502-17510	clinical	_
131-50	17511-17519	symptoms	_
131-51	17520-17521	.	_

Text=The correlation analyses were restricted to the subjects rated within a month of the scan session.
132-1	17522-17525	The	_
132-2	17526-17537	correlation	_
132-3	17538-17546	analyses	_
132-4	17547-17551	were	_
132-5	17552-17562	restricted	_
132-6	17563-17565	to	_
132-7	17566-17569	the	_
132-8	17570-17578	subjects	_
132-9	17579-17584	rated	_
132-10	17585-17591	within	_
132-11	17592-17593	a	_
132-12	17594-17599	month	_
132-13	17600-17602	of	_
132-14	17603-17606	the	_
132-15	17607-17611	scan	_
132-16	17612-17619	session	_
132-17	17620-17621	.	_

Text=The significance level was set to p <0.05 (without correction) for correlation analyses.
133-1	17622-17625	The	_
133-2	17626-17638	significance	_
133-3	17639-17644	level	_
133-4	17645-17648	was	_
133-5	17649-17652	set	_
133-6	17653-17655	to	_
133-7	17656-17657	p	_
133-8	17658-17659	<	_
133-9	17660-17664	0.05	_
133-10	17665-17666	(	_
133-11	17667-17674	without	_
133-12	17675-17685	correction	_
133-13	17686-17687	)	_
133-14	17688-17691	for	_
133-15	17692-17703	correlation	_
133-16	17704-17712	analyses	_
133-17	17713-17714	.	_

Text=In our work, the connectivity states were estimated from each group ’ s time-varying connectivity, separately.
134-1	17715-17717	In	_
134-2	17718-17721	our	_
134-3	17722-17726	work	_
134-4	17727-17728	,	_
134-5	17729-17732	the	_
134-6	17733-17745	connectivity	_
134-7	17746-17752	states	_
134-8	17753-17757	were	_
134-9	17758-17767	estimated	_
134-10	17768-17772	from	_
134-11	17773-17777	each	_
134-12	17778-17783	group	_
134-13	17784-17785	’	_
134-14	17786-17787	s	_
134-15	17788-17800	time-varying	_
134-16	17801-17813	connectivity	_
134-17	17814-17815	,	_
134-18	17816-17826	separately	_
134-19	17827-17828	.	_

Text=Since this strategy may raise concerns on whether the identified group differences were due to the grouping, we performed a permutation test (including 1000 permutation runs) to verify the effectiveness.
135-1	17829-17834	Since	_
135-2	17835-17839	this	_
135-3	17840-17848	strategy	_
135-4	17849-17852	may	_
135-5	17853-17858	raise	_
135-6	17859-17867	concerns	_
135-7	17868-17870	on	_
135-8	17871-17878	whether	_
135-9	17879-17882	the	_
135-10	17883-17893	identified	_
135-11	17894-17899	group	_
135-12	17900-17911	differences	_
135-13	17912-17916	were	_
135-14	17917-17920	due	_
135-15	17921-17923	to	_
135-16	17924-17927	the	_
135-17	17928-17936	grouping	_
135-18	17937-17938	,	_
135-19	17939-17941	we	_
135-20	17942-17951	performed	_
135-21	17952-17953	a	_
135-22	17954-17965	permutation	_
135-23	17966-17970	test	_
135-24	17971-17972	(	_
135-25	17973-17982	including	_
135-26	17983-17987	1000	_
135-27	17988-17999	permutation	_
135-28	18000-18004	runs	_
135-29	18005-18006	)	_
135-30	18007-18009	to	_
135-31	18010-18016	verify	_
135-32	18017-18020	the	_
135-33	18021-18034	effectiveness	_
135-34	18035-18036	.	_

Text=Regarding each of 1000 permutations, we performed the following three steps.
136-1	18037-18046	Regarding	_
136-2	18047-18051	each	_
136-3	18052-18054	of	_
136-4	18055-18059	1000	_
136-5	18060-18072	permutations	_
136-6	18073-18074	,	_
136-7	18075-18077	we	_
136-8	18078-18087	performed	_
136-9	18088-18091	the	_
136-10	18092-18101	following	_
136-11	18102-18107	three	_
136-12	18108-18113	steps	_
136-13	18114-18115	.	_

Text=(1) We generated three dummy groups by randomly rearranging all subjects of the original three groups (i.e., HC, CHR and ESZ groups).
137-1	18116-18117	(	_
137-2	18118-18119	1	_
137-3	18120-18121	)	_
137-4	18122-18124	We	_
137-5	18125-18134	generated	_
137-6	18135-18140	three	_
137-7	18141-18146	dummy	_
137-8	18147-18153	groups	_
137-9	18154-18156	by	_
137-10	18157-18165	randomly	_
137-11	18166-18177	rearranging	_
137-12	18178-18181	all	_
137-13	18182-18190	subjects	_
137-14	18191-18193	of	_
137-15	18194-18197	the	_
137-16	18198-18206	original	_
137-17	18207-18212	three	_
137-18	18213-18219	groups	_
137-19	18220-18221	(	_
137-20	18222-18226	i.e.	_
137-21	18227-18228	,	_
137-22	18229-18231	HC	_
137-23	18232-18233	,	_
137-24	18234-18237	CHR	_
137-25	18238-18241	and	_
137-26	18242-18245	ESZ	_
137-27	18246-18252	groups	_
137-28	18253-18254	)	_
137-29	18255-18256	.	_

Text=Each of the dummy group had the same number of subjects with the original group.
138-1	18257-18261	Each	_
138-2	18262-18264	of	_
138-3	18265-18268	the	_
138-4	18269-18274	dummy	_
138-5	18275-18280	group	_
138-6	18281-18284	had	_
138-7	18285-18288	the	_
138-8	18289-18293	same	_
138-9	18294-18300	number	_
138-10	18301-18303	of	_
138-11	18304-18312	subjects	_
138-12	18313-18317	with	_
138-13	18318-18321	the	_
138-14	18322-18330	original	_
138-15	18331-18336	group	_
138-16	18337-18338	.	_

Text=(2) Consistent with the processing on the original groups, we first estimated the group-level states by performing ICA on the dynamic connectivity of each dummy group, and then identified the dominant group-level state, finally computed the corresponding dominant subject-specific states.
139-1	18339-18340	(	_
139-2	18341-18342	2	_
139-3	18343-18344	)	_
139-4	18345-18355	Consistent	_
139-5	18356-18360	with	_
139-6	18361-18364	the	_
139-7	18365-18375	processing	_
139-8	18376-18378	on	_
139-9	18379-18382	the	_
139-10	18383-18391	original	_
139-11	18392-18398	groups	_
139-12	18399-18400	,	_
139-13	18401-18403	we	_
139-14	18404-18409	first	_
139-15	18410-18419	estimated	_
139-16	18420-18423	the	_
139-17	18424-18435	group-level	_
139-18	18436-18442	states	_
139-19	18443-18445	by	_
139-20	18446-18456	performing	_
139-21	18457-18460	ICA	_
139-22	18461-18463	on	_
139-23	18464-18467	the	_
139-24	18468-18475	dynamic	_
139-25	18476-18488	connectivity	_
139-26	18489-18491	of	_
139-27	18492-18496	each	_
139-28	18497-18502	dummy	_
139-29	18503-18508	group	_
139-30	18509-18510	,	_
139-31	18511-18514	and	_
139-32	18515-18519	then	_
139-33	18520-18530	identified	_
139-34	18531-18534	the	_
139-35	18535-18543	dominant	_
139-36	18544-18555	group-level	_
139-37	18556-18561	state	_
139-38	18562-18563	,	_
139-39	18564-18571	finally	_
139-40	18572-18580	computed	_
139-41	18581-18584	the	_
139-42	18585-18598	corresponding	_
139-43	18599-18607	dominant	_
139-44	18608-18624	subject-specific	_
139-45	18625-18631	states	_
139-46	18632-18633	.	_

Text=(3) We employed ANCOVA on each FC ’ s strengths of the dominant subject-specific states for the three dummy groups.
140-1	18634-18635	(	_
140-2	18636-18637	3	_
140-3	18638-18639	)	_
140-4	18640-18642	We	_
140-5	18643-18651	employed	_
140-6	18652-18658	ANCOVA	_
140-7	18659-18661	on	_
140-8	18662-18666	each	_
140-9	18667-18669	FC	_
140-10	18670-18671	’	_
140-11	18672-18673	s	_
140-12	18674-18683	strengths	_
140-13	18684-18686	of	_
140-14	18687-18690	the	_
140-15	18691-18699	dominant	_
140-16	18700-18716	subject-specific	_
140-17	18717-18723	states	_
140-18	18724-18727	for	_
140-19	18728-18731	the	_
140-20	18732-18737	three	_
140-21	18738-18743	dummy	_
140-22	18744-18750	groups	_
140-23	18751-18752	.	_

Text=While performing ANCOVA, the used age and gender information of each subject was the subject ’ s real information.
141-1	18753-18758	While	_
141-2	18759-18769	performing	_
141-3	18770-18776	ANCOVA	_
141-4	18777-18778	,	_
141-5	18779-18782	the	_
141-6	18783-18787	used	_
141-7	18788-18791	age	_
141-8	18792-18795	and	_
141-9	18796-18802	gender	_
141-10	18803-18814	information	_
141-11	18815-18817	of	_
141-12	18818-18822	each	_
141-13	18823-18830	subject	_
141-14	18831-18834	was	_
141-15	18835-18838	the	_
141-16	18839-18846	subject	_
141-17	18847-18848	’	_
141-18	18849-18850	s	_
141-19	18851-18855	real	_
141-20	18856-18867	information	_
141-21	18868-18869	.	_

Text=After the 1000 permutation runs, we summarized the permutation test ’ s result by calculating the occurring frequency of the case where the p-value obtained from ANCOVA using rearranged groups (i.e., the dummy groups) was smaller than the corresponding p-value obtained from ANCOVA using the original (i.e., real) groups.
142-1	18870-18875	After	_
142-2	18876-18879	the	_
142-3	18880-18884	1000	_
142-4	18885-18896	permutation	_
142-5	18897-18901	runs	_
142-6	18902-18903	,	_
142-7	18904-18906	we	_
142-8	18907-18917	summarized	_
142-9	18918-18921	the	_
142-10	18922-18933	permutation	_
142-11	18934-18938	test	_
142-12	18939-18940	’	_
142-13	18941-18942	s	_
142-14	18943-18949	result	_
142-15	18950-18952	by	_
142-16	18953-18964	calculating	_
142-17	18965-18968	the	_
142-18	18969-18978	occurring	_
142-19	18979-18988	frequency	_
142-20	18989-18991	of	_
142-21	18992-18995	the	_
142-22	18996-19000	case	_
142-23	19001-19006	where	_
142-24	19007-19010	the	_
142-25	19011-19018	p-value	_
142-26	19019-19027	obtained	_
142-27	19028-19032	from	_
142-28	19033-19039	ANCOVA	_
142-29	19040-19045	using	_
142-30	19046-19056	rearranged	_
142-31	19057-19063	groups	_
142-32	19064-19065	(	_
142-33	19066-19070	i.e.	_
142-34	19071-19072	,	_
142-35	19073-19076	the	_
142-36	19077-19082	dummy	_
142-37	19083-19089	groups	_
142-38	19090-19091	)	_
142-39	19092-19095	was	_
142-40	19096-19103	smaller	_
142-41	19104-19108	than	_
142-42	19109-19112	the	_
142-43	19113-19126	corresponding	_
142-44	19127-19134	p-value	_
142-45	19135-19143	obtained	_
142-46	19144-19148	from	_
142-47	19149-19155	ANCOVA	_
142-48	19156-19161	using	_
142-49	19162-19165	the	_
142-50	19166-19174	original	_
142-51	19175-19176	(	_
142-52	19177-19181	i.e.	_
142-53	19182-19183	,	_
142-54	19184-19188	real	_
142-55	19189-19190	)	_
142-56	19191-19197	groups	_
142-57	19198-19199	.	_

Text=The frequency (i.e., the tail probability computed from 1000 permutations) reflects the significance level of the identified group difference.
143-1	19200-19203	The	_
143-2	19204-19213	frequency	_
143-3	19214-19215	(	_
143-4	19216-19220	i.e.	_
143-5	19221-19222	,	_
143-6	19223-19226	the	_
143-7	19227-19231	tail	_
143-8	19232-19243	probability	_
143-9	19244-19252	computed	_
143-10	19253-19257	from	_
143-11	19258-19262	1000	_
143-12	19263-19275	permutations	_
143-13	19276-19277	)	_
143-14	19278-19286	reflects	_
143-15	19287-19290	the	_
143-16	19291-19303	significance	_
143-17	19304-19309	level	_
143-18	19310-19312	of	_
143-19	19313-19316	the	_
143-20	19317-19327	identified	_
143-21	19328-19333	group	_
143-22	19334-19344	difference	_
143-23	19345-19346	.	_

Text=Smaller tail probability corresponds to lower possibility of false positives of the identified group difference.
144-1	19347-19354	Smaller	_
144-2	19355-19359	tail	_
144-3	19360-19371	probability	_
144-4	19372-19383	corresponds	_
144-5	19384-19386	to	_
144-6	19387-19392	lower	_
144-7	19393-19404	possibility	_
144-8	19405-19407	of	_
144-9	19408-19413	false	_
144-10	19414-19423	positives	_
144-11	19424-19426	of	_
144-12	19427-19430	the	_
144-13	19431-19441	identified	_
144-14	19442-19447	group	_
144-15	19448-19458	difference	_
144-16	19459-19460	.	_

Text=(4) In order to identify FCs showing significant group differences in the permutation test, we further performed a step-down minP method proposed by Westfall & Young (; Peter H. Westfall and Young, 1993) for multiple comparison corrections based on the p-values from 1000 permutations.
145-1	19461-19462	(	_
145-2	19463-19464	4	_
145-3	19465-19466	)	_
145-4	19467-19469	In	_
145-5	19470-19475	order	_
145-6	19476-19478	to	_
145-7	19479-19487	identify	_
145-8	19488-19491	FCs	_
145-9	19492-19499	showing	_
145-10	19500-19511	significant	_
145-11	19512-19517	group	_
145-12	19518-19529	differences	_
145-13	19530-19532	in	_
145-14	19533-19536	the	_
145-15	19537-19548	permutation	_
145-16	19549-19553	test	_
145-17	19554-19555	,	_
145-18	19556-19558	we	_
145-19	19559-19566	further	_
145-20	19567-19576	performed	_
145-21	19577-19578	a	_
145-22	19579-19588	step-down	_
145-23	19589-19593	minP	_
145-24	19594-19600	method	_
145-25	19601-19609	proposed	_
145-26	19610-19612	by	_
145-27	19613-19621	Westfall	_
145-28	19622-19623	&	_
145-29	19624-19629	Young	_
145-30	19630-19631	(	_
145-31	19632-19633	;	_
145-32	19634-19639	Peter	_
145-33	19640-19642	H.	_
145-34	19643-19651	Westfall	_
145-35	19652-19655	and	_
145-36	19656-19661	Young	_
145-37	19662-19663	,	_
145-38	19664-19668	1993	_
145-39	19669-19670	)	_
145-40	19671-19674	for	_
145-41	19675-19683	multiple	_
145-42	19684-19694	comparison	_
145-43	19695-19706	corrections	_
145-44	19707-19712	based	_
145-45	19713-19715	on	_
145-46	19716-19719	the	_
145-47	19720-19728	p-values	_
145-48	19729-19733	from	_
145-49	19734-19738	1000	_
145-50	19739-19751	permutations	_
145-51	19752-19753	.	_

Text=After obtaining the adjusted p-values for all FCs, FCs with significant group differences can be identified.
146-1	19754-19759	After	_
146-2	19760-19769	obtaining	_
146-3	19770-19773	the	_
146-4	19774-19782	adjusted	_
146-5	19783-19791	p-values	_
146-6	19792-19795	for	_
146-7	19796-19799	all	_
146-8	19800-19803	FCs	_
146-9	19804-19805	,	_
146-10	19806-19809	FCs	_
146-11	19810-19814	with	_
146-12	19815-19826	significant	_
146-13	19827-19832	group	_
146-14	19833-19844	differences	_
146-15	19845-19848	can	_
146-16	19849-19851	be	_
146-17	19852-19862	identified	_
146-18	19863-19864	.	_

